

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Promising neuroprotective strategies for... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1907/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1907" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury" />
    
            <meta name="og:title" content="F1000Research Article: Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury.">
            <meta name="og:description" content="Read the latest article version by Antigona Ulndreaj, Anna Badner, Michael G Fehlings, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12564">
            <meta name="article-id" content="11633">
            <meta name="dc.title" content="Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury">
            <meta name="dc.description" content="Traumatic spinal cord injury (SCI) is a devastating condition of motor, sensory, and autonomic dysfunction.&amp;nbsp;The significant cost associated with the management and lifetime care of patients with SCI also presents a major economic burden. For these reasons, there is a need to develop and translate strategies that can improve outcomes following SCI. Given the challenges in achieving regeneration of the injured spinal cord, neuroprotection has been at the forefront of clinical translation. Yet, despite many preclinical advances, there has been limited translation into the clinic apart from methylprednisolone (which remains controversial), hypertensive therapy to maintain spinal cord perfusion, and early decompressive surgery. While there are several factors related to the limited translational success, including the clinical and mechanistic heterogeneity of human SCI, the misalignment between animal models of SCI and clinical reality continues to be an important factor. Whereas most clinical cases are at the cervical level, only a small fraction of preclinical research is conducted in cervical models of SCI. Therefore, this review highlights the most promising neuroprotective and neural reparative therapeutic strategies undergoing clinical assessment, including riluzole, hypothermia, granulocyte colony-stimulating factor, glibenclamide, minocycline, Cethrin (VX-210), and anti-Nogo-A antibody, and emphasizes their efficacy in relation to the anatomical level of injury. Our hope is that more basic research will be conducted in clinically relevant cervical SCI models in order to expedite the transition of important laboratory discoveries into meaningful treatment options for patients with SCI.">
            <meta name="dc.subject" content="Traumatic spinal cord injury, neuroprotective treatments, granulocyte colony stimulating fact">
            <meta name="dc.creator" content="Ulndreaj, Antigona">
            <meta name="dc.creator" content="Badner, Anna">
            <meta name="dc.creator" content="Fehlings, Michael G">
            <meta name="dc.date" content="2017/10/30">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11633.1">
            <meta name="dc.source" content="F1000Research 2017 6:1907">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Traumatic spinal cord injury">
            <meta name="prism.keyword" content="neuroprotective treatments">
            <meta name="prism.keyword" content="granulocyte colony stimulating fact">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/10/30">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1907">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11633.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1907">
            <meta name="citation_title" content="Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury">
            <meta name="citation_abstract" content="Traumatic spinal cord injury (SCI) is a devastating condition of motor, sensory, and autonomic dysfunction.&amp;nbsp;The significant cost associated with the management and lifetime care of patients with SCI also presents a major economic burden. For these reasons, there is a need to develop and translate strategies that can improve outcomes following SCI. Given the challenges in achieving regeneration of the injured spinal cord, neuroprotection has been at the forefront of clinical translation. Yet, despite many preclinical advances, there has been limited translation into the clinic apart from methylprednisolone (which remains controversial), hypertensive therapy to maintain spinal cord perfusion, and early decompressive surgery. While there are several factors related to the limited translational success, including the clinical and mechanistic heterogeneity of human SCI, the misalignment between animal models of SCI and clinical reality continues to be an important factor. Whereas most clinical cases are at the cervical level, only a small fraction of preclinical research is conducted in cervical models of SCI. Therefore, this review highlights the most promising neuroprotective and neural reparative therapeutic strategies undergoing clinical assessment, including riluzole, hypothermia, granulocyte colony-stimulating factor, glibenclamide, minocycline, Cethrin (VX-210), and anti-Nogo-A antibody, and emphasizes their efficacy in relation to the anatomical level of injury. Our hope is that more basic research will be conducted in clinically relevant cervical SCI models in order to expedite the transition of important laboratory discoveries into meaningful treatment options for patients with SCI.">
            <meta name="citation_description" content="Traumatic spinal cord injury (SCI) is a devastating condition of motor, sensory, and autonomic dysfunction.&amp;nbsp;The significant cost associated with the management and lifetime care of patients with SCI also presents a major economic burden. For these reasons, there is a need to develop and translate strategies that can improve outcomes following SCI. Given the challenges in achieving regeneration of the injured spinal cord, neuroprotection has been at the forefront of clinical translation. Yet, despite many preclinical advances, there has been limited translation into the clinic apart from methylprednisolone (which remains controversial), hypertensive therapy to maintain spinal cord perfusion, and early decompressive surgery. While there are several factors related to the limited translational success, including the clinical and mechanistic heterogeneity of human SCI, the misalignment between animal models of SCI and clinical reality continues to be an important factor. Whereas most clinical cases are at the cervical level, only a small fraction of preclinical research is conducted in cervical models of SCI. Therefore, this review highlights the most promising neuroprotective and neural reparative therapeutic strategies undergoing clinical assessment, including riluzole, hypothermia, granulocyte colony-stimulating factor, glibenclamide, minocycline, Cethrin (VX-210), and anti-Nogo-A antibody, and emphasizes their efficacy in relation to the anatomical level of injury. Our hope is that more basic research will be conducted in clinically relevant cervical SCI models in order to expedite the transition of important laboratory discoveries into meaningful treatment options for patients with SCI.">
            <meta name="citation_keywords" content="Traumatic spinal cord injury, neuroprotective treatments, granulocyte colony stimulating fact">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Antigona Ulndreaj">
            <meta name="citation_author_institution" content="Institute of Medical Science, University of Toronto, Toronto, Canada">
            <meta name="citation_author_institution" content="University of Toronto Spine Program, Toronto, Canada">
            <meta name="citation_author_institution" content="Department of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Canada">
            <meta name="citation_author" content="Anna Badner">
            <meta name="citation_author_institution" content="Institute of Medical Science, University of Toronto, Toronto, Canada">
            <meta name="citation_author_institution" content="University of Toronto Spine Program, Toronto, Canada">
            <meta name="citation_author_institution" content="Department of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Canada">
            <meta name="citation_author" content="Michael G Fehlings">
            <meta name="citation_author_institution" content="Institute of Medical Science, University of Toronto, Toronto, Canada">
            <meta name="citation_author_institution" content="University of Toronto Spine Program, Toronto, Canada">
            <meta name="citation_author_institution" content="Department of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Canada">
            <meta name="citation_publication_date" content="2017/10/30">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1907">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11633.1">
            <meta name="citation_firstpage" content="1907">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1907/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1907.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12564 /> <input type=hidden id=articleId name=articleId value=11633 /> <input type=hidden id=xmlUrl value="/articles/6-1907/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1907-v1.xml"> <input type=hidden id=article_uuid value=fd432497-1a7a-49d1-99e4-096769ec9ba6 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11633.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11633.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1907"
  },
  "headline": "Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects...",
  "datePublished": "2017-10-30T12:14:42",
  "dateModified": "2017-10-30T12:14:42",
  "author": [
    {
      "@type": "Person",
      "name": "Antigona Ulndreaj"
    },    {
      "@type": "Person",
      "name": "Anna Badner"
    },    {
      "@type": "Person",
      "name": "Michael G Fehlings"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Traumatic spinal cord injury (SCI) is a devastating condition of motor, sensory, and autonomic dysfunction. The significant cost associated with the management and lifetime care of patients with SCI also presents a major economic burden. For these reasons, there is a need to develop and translate strategies that can improve outcomes following SCI. Given the challenges in achieving regeneration of the injured spinal cord, neuroprotection has been at the forefront of clinical translation. Yet, despite many preclinical advances, there has been limited translation into the clinic apart from methylprednisolone (which remains controversial), hypertensive therapy to maintain spinal cord perfusion, and early decompressive surgery. While there are several factors related to the limited translational success, including the clinical and mechanistic heterogeneity of human SCI, the misalignment between animal models of SCI and clinical reality continues to be an important factor. Whereas most clinical cases are at the cervical level, only a small fraction of preclinical research is conducted in cervical models of SCI. Therefore, this review highlights the most promising neuroprotective and neural reparative therapeutic strategies undergoing clinical assessment, including riluzole, hypothermia, granulocyte colony-stimulating factor, glibenclamide, minocycline, Cethrin (VX-210), and anti-Nogo-A antibody, and emphasizes their efficacy in relation to the anatomical level of injury. Our hope is that more basic research will be conducted in clinically relevant cervical SCI models in order to expedite the transition of important laboratory discoveries into meaningful treatment options for patients with SCI."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1907/v1",
            "name": "Promising neuroprotective strategies for traumatic spinal cord injury..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Promising neuroprotective strategies for traumatic spinal cord injury... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12564 data-id=11633 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11633.1" data-recommended="" data-doi="10.12688/f1000research.11633.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1907/v1/pdf?article_uuid=fd432497-1a7a-49d1-99e4-096769ec9ba6" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11633-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11633-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11633-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Ulndreaj A, Badner A and Fehlings MG. Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1907 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11633.1" target=_blank>https://doi.org/10.12688/f1000research.11633.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11633-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11633 id=track-article-signin-11633 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11633?target=/articles/6-1907/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12564 /> <input name=articleId type=hidden value=11633 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Antigona Ulndreaj<sup>1-3</sup>,&nbsp;</span><span class="">Anna Badner<sup>1-3</sup>,&nbsp;</span><span class=""><a href="mailto:Michael.Fehlings@uhn.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michael G Fehlings</span></a><a href="https://orcid.org/0000-0002-5722-6364" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5722-6364</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Antigona Ulndreaj<sup>1-3</sup>,&nbsp;</span><span class="">Anna Badner<sup>1-3</sup>,&nbsp;</span><span class=""><a href="mailto:Michael.Fehlings@uhn.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michael G Fehlings</span></a><a href="http://orcid.org/0000-0002-5722-6364" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5722-6364</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 30 Oct 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11633.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Institute of Medical Science, University of Toronto, Toronto, Canada<br/> <sup>2</sup> University of Toronto Spine Program, Toronto, Canada<br/> <sup>3</sup> Department of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Canada<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27359-27287></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15079-27285></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Traumatic spinal cord injury (SCI) is a devastating condition of motor, sensory, and autonomic dysfunction.&nbsp;The significant cost associated with the management and lifetime care of patients with SCI also presents a major economic burden. For these reasons, there is a need to develop and translate strategies that can improve outcomes following SCI. Given the challenges in achieving regeneration of the injured spinal cord, neuroprotection has been at the forefront of clinical translation. Yet, despite many preclinical advances, there has been limited translation into the clinic apart from methylprednisolone (which remains controversial), hypertensive therapy to maintain spinal cord perfusion, and early decompressive surgery. While there are several factors related to the limited translational success, including the clinical and mechanistic heterogeneity of human SCI, the misalignment between animal models of SCI and clinical reality continues to be an important factor. Whereas most clinical cases are at the cervical level, only a small fraction of preclinical research is conducted in cervical models of SCI. Therefore, this review highlights the most promising neuroprotective and neural reparative therapeutic strategies undergoing clinical assessment, including riluzole, hypothermia, granulocyte colony-stimulating factor, glibenclamide, minocycline, Cethrin (VX-210), and anti-Nogo-A antibody, and emphasizes their efficacy in relation to the anatomical level of injury. Our hope is that more basic research will be conducted in clinically relevant cervical SCI models in order to expedite the transition of important laboratory discoveries into meaningful treatment options for patients with SCI. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Traumatic spinal cord injury, neuroprotective treatments, granulocyte colony stimulating fact </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Michael G Fehlings (<a href="mailto:Michael.Fehlings@uhn.ca">Michael.Fehlings@uhn.ca</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Michael G Fehlings </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Ulndreaj A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Ulndreaj A, Badner A and Fehlings MG. Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1907 (<a href="https://doi.org/10.12688/f1000research.11633.1" target=_blank>https://doi.org/10.12688/f1000research.11633.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 30 Oct 2017, <b>6</b>(F1000 Faculty Rev):1907 (<a href="https://doi.org/10.12688/f1000research.11633.1" target=_blank>https://doi.org/10.12688/f1000research.11633.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 30 Oct 2017, <b>6</b>(F1000 Faculty Rev):1907 (<a href="https://doi.org/10.12688/f1000research.11633.1" target=_blank>https://doi.org/10.12688/f1000research.11633.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d10682e201>Introduction</h2><p class="" id=d10682e204>Traumatic spinal cord injury (SCI), which is caused by external mechanical impact, results in impairment of motor, sensory, and autonomic function at and below the level of injury. Mechanical laceration, contusion, and compression result in cell death, which is further propagated by secondary injury mechanisms which include ischemia, sodium- and calcium-mediated cell injury, glutamatergic excitotoxicity, hemorrhage, and inflammation. The secondary injury amplifies the primary damage and promotes cystic degeneration and glial scar formation, thereby preventing functional recovery. Therefore, targeting secondary injury is a promising therapeutic intervention.</p><p class="" id=d10682e207>Despite several efficacious preclinical studies for SCI, there have been challenges in achieving successful translation into the clinic. While the disconnect between bench and bedside is not limited to SCI, it is important to recognize the underlying factors and identify solutions. Clinical heterogeneity, complexity of the disease, and the limited regenerative capacity of the spinal cord are among the key causes for poor translation and have been broadly discussed in the literature<sup><a href="#ref-1">1</a></sup>. Yet significantly less emphasis has been placed on the need to apply clinically relevant models of cervical SCI<sup><a href="#ref-2">2</a></sup>. Given that over 50% of human SCI cases occur at the cervical level<sup><a href="#ref-3">3</a></sup> and the majority of preclinical work involves thoracic injuries (<a href="#T1">Table 1</a>), translation will require a greater understanding of injury-level subpopulation differences in pathophysiology and therapeutic benefits.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Experimental evidence for the efficacy of promising neuroprotective therapies.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d10682e236 class=n-a></a><thead><a name=d10682e238 class=n-a></a><tr><a name=d10682e240 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e242 class=n-a></a>Neuroprotective/<br class=br>neural reparative<br class=br>therapy</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e249 class=n-a></a>Injury model, species</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e252 class=n-a></a>Reference</th></tr></thead><tbody><a name=d10682e257 class=n-a></a><tr><a name=d10682e259 class=n-a></a><td colspan=1 rowspan=13 valign=top><a name=d10682e261 class=n-a></a>Riluzole</td><td colspan=1 rowspan=1 valign=top><a name=d10682e264 class=n-a></a>Contusion, T7–T10, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e267 class=n-a></a><a href="#ref-69">69</a></td></tr><tr><a name=d10682e272 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e274 class=n-a></a>Compression, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e277 class=n-a></a><a href="#ref-70">70</a></td></tr><tr><a name=d10682e282 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e284 class=n-a></a>Compression, T6, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e287 class=n-a></a><a href="#ref-71">71</a></td></tr><tr><a name=d10682e292 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e294 class=n-a></a>Contusion, T10, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e297 class=n-a></a><a href="#ref-72">72</a></td></tr><tr><a name=d10682e302 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e304 class=n-a></a>Compression, T11, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e307 class=n-a></a><a href="#ref-73">73</a></td></tr><tr><a name=d10682e313 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e315 class=n-a></a>Contusion, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e318 class=n-a></a><a href="#ref-74">74</a></td></tr><tr><a name=d10682e323 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e325 class=n-a></a>Unilateral contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e328 class=n-a></a><a href="#ref-75">75</a></td></tr><tr><a name=d10682e333 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e335 class=n-a></a>Hemisection, C2, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e338 class=n-a></a><a href="#ref-35">35</a></td></tr><tr><a name=d10682e343 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e345 class=n-a></a>Compression, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e348 class=n-a></a><a href="#ref-76">76</a></td></tr><tr><a name=d10682e353 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e355 class=n-a></a>Unilateral contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e358 class=n-a></a><a href="#ref-77">77</a></td></tr><tr><a name=d10682e363 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e365 class=n-a></a>Compression, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e368 class=n-a></a><a href="#ref-78">78</a></td></tr><tr><a name=d10682e374 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e376 class=n-a></a>Compression, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e379 class=n-a></a><a href="#ref-79">79</a></td></tr><tr><a name=d10682e384 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e386 class=n-a></a>Transection, S2, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e389 class=n-a></a><a href="#ref-34">34</a></td></tr><tr><a name=d10682e394 class=n-a></a><td colspan=1 rowspan=8 valign=top><a name=d10682e396 class=n-a></a>Hypothermia</td><td colspan=1 rowspan=1 valign=top><a name=d10682e399 class=n-a></a>Contusion, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e402 class=n-a></a><a href="#ref-80">80</a></td></tr><tr><a name=d10682e407 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e409 class=n-a></a>Compression, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e412 class=n-a></a><a href="#ref-81">81</a></td></tr><tr><a name=d10682e417 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e419 class=n-a></a>Compression, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e422 class=n-a></a><a href="#ref-82">82</a></td></tr><tr><a name=d10682e427 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e429 class=n-a></a>Compression, T11, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e432 class=n-a></a><a href="#ref-83">83</a></td></tr><tr><a name=d10682e438 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e440 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e443 class=n-a></a><a href="#ref-84">84</a></td></tr><tr><a name=d10682e448 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e450 class=n-a></a>Contusion, T10, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e453 class=n-a></a><a href="#ref-85">85</a></td></tr><tr><a name=d10682e458 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e460 class=n-a></a>Unilateral contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e463 class=n-a></a><a href="#ref-75">75</a></td></tr><tr><a name=d10682e468 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e470 class=n-a></a>Contusion, C5, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e473 class=n-a></a><a href="#ref-86">86</a></td></tr><tr><a name=d10682e478 class=n-a></a><td colspan=1 rowspan=8 valign=top><a name=d10682e480 class=n-a></a>Glibenclamide</td><td colspan=1 rowspan=1 valign=top><a name=d10682e483 class=n-a></a>Contusion, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e486 class=n-a></a><a href="#ref-87">87</a></td></tr><tr><a name=d10682e491 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e493 class=n-a></a>Unilateral contusion, T9, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e496 class=n-a></a><a href="#ref-88">88</a></td></tr><tr><a name=d10682e502 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e504 class=n-a></a>Unilateral contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e507 class=n-a></a><a href="#ref-75">75</a></td></tr><tr><a name=d10682e512 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e514 class=n-a></a>Unilateral contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e517 class=n-a></a><a href="#ref-89">89</a></td></tr><tr><a name=d10682e522 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e524 class=n-a></a>Contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e527 class=n-a></a><a href="#ref-90">90</a></td></tr><tr><a name=d10682e532 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e534 class=n-a></a>Unilateral contusion, C4, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e537 class=n-a></a><a href="#ref-42">42</a></td></tr><tr><a name=d10682e542 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e544 class=n-a></a>Unilateral contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e547 class=n-a></a><a href="#ref-77">77</a></td></tr><tr><a name=d10682e552 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e554 class=n-a></a>Unilateral contusion, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e557 class=n-a></a><a href="#ref-91">91</a></td></tr><tr><a name=d10682e563 class=n-a></a><td colspan=1 rowspan=12 valign=top><a name=d10682e565 class=n-a></a>Granulocyte<br class=br>colony-stimulating<br class=br>factor</td><td colspan=1 rowspan=1 valign=top><a name=d10682e572 class=n-a></a>Contusion, T10, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e575 class=n-a></a><a href="#ref-92">92</a></td></tr><tr><a name=d10682e580 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e582 class=n-a></a>Compression, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e585 class=n-a></a><a href="#ref-93">93</a></td></tr><tr><a name=d10682e590 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e592 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e595 class=n-a></a><a href="#ref-94">94</a></td></tr><tr><a name=d10682e600 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e602 class=n-a></a>Hemisection, T10, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e605 class=n-a></a><a href="#ref-95">95</a></td></tr><tr><a name=d10682e610 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e612 class=n-a></a>Contusion, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e615 class=n-a></a><a href="#ref-96">96</a></td></tr><tr><a name=d10682e620 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e622 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e625 class=n-a></a><a href="#ref-97">97</a></td></tr><tr><a name=d10682e631 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e633 class=n-a></a>Contusion, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e636 class=n-a></a><a href="#ref-44">44</a></td></tr><tr><a name=d10682e641 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e643 class=n-a></a>Compression, T8, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e646 class=n-a></a><a href="#ref-98">98</a></td></tr><tr><a name=d10682e651 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e653 class=n-a></a>Compression, T7, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e656 class=n-a></a><a href="#ref-99">99</a></td></tr><tr><a name=d10682e661 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e663 class=n-a></a>Transection, T8, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e666 class=n-a></a><a href="#ref-100">100</a></td></tr><tr><a name=d10682e671 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e673 class=n-a></a>Contusion, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e676 class=n-a></a><a href="#ref-101">101</a></td></tr><tr><a name=d10682e681 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e683 class=n-a></a>Compression, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e686 class=n-a></a><a href="#ref-102">102</a></td></tr><tr><a name=d10682e692 class=n-a></a><td colspan=1 rowspan=13 valign=top><a name=d10682e694 class=n-a></a>Minocycline</td><td colspan=1 rowspan=1 valign=top><a name=d10682e697 class=n-a></a>Contusion, T7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e700 class=n-a></a><a href="#ref-103">103</a></td></tr><tr><a name=d10682e705 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e707 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e710 class=n-a></a><a href="#ref-104">104</a></td></tr><tr><a name=d10682e715 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e717 class=n-a></a>Contusion, T9, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e720 class=n-a></a><a href="#ref-105">105</a></td></tr><tr><a name=d10682e725 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e727 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e730 class=n-a></a><a href="#ref-106">106</a></td></tr><tr><a name=d10682e735 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e737 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e740 class=n-a></a><a href="#ref-107">107</a></td></tr><tr><a name=d10682e745 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e747 class=n-a></a>Hemisection, T13, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e750 class=n-a></a><a href="#ref-108">108</a></td></tr><tr><a name=d10682e756 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e758 class=n-a></a>Contusion, T10, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e761 class=n-a></a><a href="#ref-109">109</a></td></tr><tr><a name=d10682e766 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e768 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e771 class=n-a></a><a href="#ref-110">110</a></td></tr><tr><a name=d10682e776 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e778 class=n-a></a>Contusion, T10, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e781 class=n-a></a><a href="#ref-111">111</a></td></tr><tr><a name=d10682e786 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e788 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e791 class=n-a></a><a href="#ref-112">112</a></td></tr><tr><a name=d10682e796 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e798 class=n-a></a>Dorsal transection, C7, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e801 class=n-a></a><a href="#ref-113">113</a></td></tr><tr><a name=d10682e806 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e808 class=n-a></a>Unilateral contusion, C5, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e811 class=n-a></a><a href="#ref-114">114</a></td></tr><tr><a name=d10682e817 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e819 class=n-a></a>Compression, T3, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e822 class=n-a></a><a href="#ref-115">115</a></td></tr><tr><a name=d10682e827 class=n-a></a><td colspan=1 rowspan=4 valign=top><a name=d10682e829 class=n-a></a>Cethrin (VX-210)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e832 class=n-a></a>Contusion, T8, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e835 class=n-a></a><a href="#ref-116">116</a></td></tr><tr><a name=d10682e840 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e842 class=n-a></a>Dorsal hemisection, T7, mouse</td><td colspan=1 rowspan=1 valign=top><a name=d10682e845 class=n-a></a><a href="#ref-117">117</a></td></tr><tr><a name=d10682e850 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e852 class=n-a></a>Dorsal transection, T3, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e855 class=n-a></a><a href="#ref-118">118</a></td></tr><tr><a name=d10682e860 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e862 class=n-a></a>Contusion, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e865 class=n-a></a><a href="#ref-119">119</a></td></tr><tr><a name=d10682e870 class=n-a></a><td colspan=1 rowspan=11 valign=top><a name=d10682e872 class=n-a></a>Anti-Nogo-A<br class=br>antibody</td><td colspan=1 rowspan=1 valign=top><a name=d10682e877 class=n-a></a>Hemisection, T10, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e880 class=n-a></a><a href="#ref-120">120</a></td></tr><tr><a name=d10682e886 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e888 class=n-a></a>Dorsolateral hemisection, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e891 class=n-a></a><a href="#ref-121">121</a></td></tr><tr><a name=d10682e896 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e898 class=n-a></a>T-shape transection, T9, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e901 class=n-a></a><a href="#ref-122">122</a></td></tr><tr><a name=d10682e906 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e908 class=n-a></a>Partial hemisection, T8, monkey</td><td colspan=1 rowspan=1 valign=top><a name=d10682e911 class=n-a></a><a href="#ref-123">123</a></td></tr><tr><a name=d10682e916 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e918 class=n-a></a>T-shape transection, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e921 class=n-a></a><a href="#ref-124">124</a></td></tr><tr><a name=d10682e926 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e928 class=n-a></a>T-shape transection, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e931 class=n-a></a><a href="#ref-125">125</a></td></tr><tr><a name=d10682e936 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e938 class=n-a></a>T-shape transection, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e941 class=n-a></a><a href="#ref-126">126</a></td></tr><tr><a name=d10682e947 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e949 class=n-a></a>Dorsal hemisection, T8, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e952 class=n-a></a><a href="#ref-50">52</a></td></tr><tr><a name=d10682e957 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e959 class=n-a></a>Partial dorsal transection, T6, rat</td><td colspan=1 rowspan=1 valign=top><a name=d10682e962 class=n-a></a><a href="#ref-53">53</a></td></tr><tr><a name=d10682e967 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e969 class=n-a></a>Partial hemisection, C7, monkey</td><td colspan=1 rowspan=1 valign=top><a name=d10682e972 class=n-a></a><a href="#ref-54">54</a></td></tr><tr><a name=d10682e977 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e979 class=n-a></a>Hemisection, C7, monkey</td><td colspan=1 rowspan=1 valign=top><a name=d10682e982 class=n-a></a><a href="#ref-55">55</a></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d10682e991 class=n-a></a><p id=d10682e993> The table summarizes the model, anatomical level of spinal cord injury, and the species used to evaluate the effectiveness and mechanisms of action of the neuroprotective therapies undergoing clinical trials. Although this list is not exhaustive, it highlights that thoracic models of spinal cord injury are most commonly applied at the preclinical level. All injury models are bilateral if not stated otherwise.</p></div></div></div><p class="" id=d10682e999>Differences between the cervical and thoracic cord anatomy, physiology, and immune response may affect the outcome of neuroprotective treatments (<a href="#f1">Figure 1</a>). Anatomically, the cervical spine has small vertebrae and increased mobility, which make it more susceptible to injury compared to the thoracic region. The cervical spinal cord also has a larger diameter, a greater blood supply, and larger gray and white matter areas<sup><a href="#ref-4">4</a></sup>. Relatedly, the cervical gray matter vasculature has less pericyte coverage than the thoracic cord, resulting in a blood spinal cord barrier predisposed to increased permeability<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. Also, some of the most frequent conditions of the spine, such as central cord syndrome<sup><a href="#ref-7">7</a></sup> and degenerative cervical myelopathy<sup><a href="#ref-8">8</a></sup>, affect primarily the cervical region. Of note, while the cervical spinal cord is especially vulnerable to injury and hemorrhage, it may also be more accessible to systemically administered therapeutics. Adding to this complexity, there is emerging evidence demonstrating level-dependent variations in the immune response<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup>. For example, interestingly, higher-level injuries may be less prone to chronic autoimmunity<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>. Therefore, as SCI pathophysiology may differ between anatomical levels of injury, there is growing awareness that treatments should be tailored to the patient’s injury. Here, we review the most promising neuroprotective approaches, emphasizing their effect differences based on the level of injury (<a href="#T2">Table 2</a>).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12564/4ab9fdfe-ed45-4311-891d-451a3f774fd9_figure1.gif"><img alt="4ab9fdfe-ed45-4311-891d-451a3f774fd9_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12564/4ab9fdfe-ed45-4311-891d-451a3f774fd9_figure1.gif"></a><div class=caption><h3>Figure 1. There are several key differences between cervical and thoracic spinal cord injury</h3><p id=d10682e1053>(<b>A</b>) The cervical vertebrae are smaller and more mobile than their thoracic counterparts, which are further supported by the rib cage. (<b>B</b>) The cervical spinal cord also has a larger diameter, and injuries at the cervical level interrupt the sympathetic innervation to major immune organs. (<b>C</b>) Moreover, the greater vascularity of the cervical cord increases susceptibility to hemorrhage following trauma. Lastly, injuries at the cervical level allow for considerably more spontaneous recovery compared with injuries at the thoracic level<sup><a href="#ref-128">128</a></sup>. BSCB, blood spinal cord barrier; SCI, spinal cord injury.</p></div></div><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Neuroprotective strategies currently in clinical trials.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d10682e1084 class=n-a></a><thead><a name=d10682e1086 class=n-a></a><tr><a name=d10682e1088 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1090 class=n-a></a>Neuroprotective/<br class=br>neural-reparative drug</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1095 class=n-a></a>ClinicalTrials.gov<br class=br>identifier</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1100 class=n-a></a>Status</th><th align=left colspan=2 rowspan=1><a name=d10682e1103 class=n-a></a>Enrollment (number of<br class=br>patients, level of injury</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1108 class=n-a></a>Results</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1112 class=n-a></a>Mechanism of action</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1115 class=n-a></a>Reference</th></tr><tr><a name=d10682e1119 class=n-a></a><th colspan=1 rowspan=1><a name=d10682e1121 class=n-a></a></th><th colspan=1 rowspan=1><a name=d10682e1123 class=n-a></a></th><th colspan=1 rowspan=1><a name=d10682e1125 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1127 class=n-a></a>Thoracic</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10682e1130 class=n-a></a>Cervical</th><th colspan=1 rowspan=1><a name=d10682e1134 class=n-a></a></th><th colspan=1 rowspan=1><a name=d10682e1136 class=n-a></a></th><th colspan=1 rowspan=1><a name=d10682e1138 class=n-a></a></th></tr></thead><tbody><a name=d10682e1142 class=n-a></a><tr><a name=d10682e1144 class=n-a></a><td colspan=1 rowspan=2 valign=top><a name=d10682e1145 class=n-a></a>Riluzole</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1148 class=n-a></a>NCT00876889</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1151 class=n-a></a>Completed</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1154 class=n-a></a>8 (T1–T11)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1157 class=n-a></a>28 (C4–C8)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1160 class=n-a></a>Motor score improvement in patients<br class=br>with cervical SCI, particularly with<br class=br>incomplete injuries. No significant<br class=br>effect in patients with thoracic SCI.</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1170 class=n-a></a>Limit excitotoxicity</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1173 class=n-a></a><a href="#ref-36">36</a></td></tr><tr><a name=d10682e1177 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e1179 class=n-a></a>NCT01597518</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1182 class=n-a></a>Recruiting</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1185 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1188 class=n-a></a>Est. enrollment<br class=br>351 (C4–C8)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1193 class=n-a></a></td><td colspan=1 rowspan=1 valign=top><a name=d10682e1196 class=n-a></a><a href="#ref-37">37</a></td></tr><tr><a name=d10682e1200 class=n-a></a><td colspan=1 rowspan=2 valign=top><a name=d10682e1201 class=n-a></a>Therapeutic<br class=br>hypothermia</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1206 class=n-a></a>N/A</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1209 class=n-a></a>Completed</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1212 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1215 class=n-a></a>14 (C4–C7)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1218 class=n-a></a>Trend toward improvement of motor<br class=br>scores compared with historical<br class=br>controls in the same institution.</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1226 class=n-a></a>Reduce excitotoxicity,<br class=br>inflammation, and<br class=br>vasogenic edema</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1233 class=n-a></a><a href="#ref-40">40</a></td></tr><tr><a name=d10682e1237 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e1239 class=n-a></a>NCT02991690</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1242 class=n-a></a>Recruiting</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1245 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1248 class=n-a></a>Est. 120 (C1–C8)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1251 class=n-a></a></td><td colspan=1 rowspan=1 valign=top><a name=d10682e1254 class=n-a></a>ClinicalTrials.gov</td></tr><tr><a name=d10682e1257 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e1258 class=n-a></a>Glibenclamide</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1261 class=n-a></a>NCT02524379</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1264 class=n-a></a>Recruiting</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1267 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1270 class=n-a></a>Est. 10 (C2–C8)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1273 class=n-a></a></td><td colspan=1 rowspan=1 valign=top><a name=d10682e1276 class=n-a></a>Limit hemorrhage</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1279 class=n-a></a>ClinicalTrials.gov</td></tr><tr><a name=d10682e1283 class=n-a></a><td colspan=1 rowspan=2 valign=top><a name=d10682e1284 class=n-a></a>Granulocyte colony-<br class=br>stimulating factor</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1289 class=n-a></a>N/A</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1292 class=n-a></a>Completed</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1295 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1298 class=n-a></a>28 (C2–C6)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1301 class=n-a></a>Motor score improvement at 3 months<br class=br>of treatment compared with MPSS<br class=br>historical controls.</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1309 class=n-a></a>Promote neurogenesis<br class=br>and angiogenesis, and<br class=br>reduce inflammation</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1316 class=n-a></a><a href="#ref-46">46</a></td></tr><tr><a name=d10682e1320 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e1322 class=n-a></a>N/A</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1325 class=n-a></a>Completed</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1328 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1331 class=n-a></a>17 (C2–C6)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1334 class=n-a></a>Motor score improvement from 1 week<br class=br>to 1 year after SCI compared with<br class=br>placebo in an open non-randomized<br class=br>trial.</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1344 class=n-a></a><a href="#ref-47">47</a></td></tr><tr><a name=d10682e1348 class=n-a></a><td colspan=1 rowspan=2 valign=top><a name=d10682e1349 class=n-a></a>Minocycline</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1352 class=n-a></a>NCT00559494</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1355 class=n-a></a>Completed</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1358 class=n-a></a>17 (T1–T12)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1361 class=n-a></a>25 (C1–C8)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1364 class=n-a></a>Motor score improvement in patients<br class=br>with cervical SCI, particularly for motor<br class=br>incomplete. No benefit for patients with<br class=br>thoracic SCI.</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1374 class=n-a></a>Reduce inflammation</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1377 class=n-a></a><a href="#ref-49">49</a></td></tr><tr><a name=d10682e1381 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e1383 class=n-a></a>NCT01828203</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1386 class=n-a></a>Recruiting</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1389 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1392 class=n-a></a>Est. 248 (C0–C8)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1395 class=n-a></a></td><td colspan=1 rowspan=1 valign=top><a name=d10682e1398 class=n-a></a>ClinicalTrials.gov</td></tr><tr><a name=d10682e1401 class=n-a></a><td colspan=1 rowspan=2 valign=top><a name=d10682e1402 class=n-a></a>Cethrin (VX-210)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1405 class=n-a></a>NCT00500812</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1408 class=n-a></a>Completed</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1411 class=n-a></a>32 (T2–T12)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1414 class=n-a></a>16 (C4–T1)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1417 class=n-a></a>Significant motor score improvement in<br class=br>patients with cervical injury. No effect<br class=br>in patients with thoracic SCI.</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1425 class=n-a></a>Inhibit axonal dieback<br class=br>and reduce inflammation</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1430 class=n-a></a><a href="#ref-50">50</a></td></tr><tr><a name=d10682e1434 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e1436 class=n-a></a>NCT02669849</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1439 class=n-a></a>Recruiting</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1442 class=n-a></a>0</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1445 class=n-a></a>Est. 150 (C5–C6)</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1448 class=n-a></a></td><td colspan=1 rowspan=1 valign=top><a name=d10682e1451 class=n-a></a>ClinicalTrials.gov</td></tr><tr><a name=d10682e1455 class=n-a></a><td colspan=1 rowspan=2 valign=top><a name=d10682e1456 class=n-a></a>Anti-Nogo-A antibody</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1459 class=n-a></a>NCT00406016</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1462 class=n-a></a>Completed</td><td colspan=2 rowspan=2 valign=top><a name=d10682e1465 class=n-a></a>52 patients with injury between<br class=br>C5 and T12; no data available<br class=br>about injury level classification</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1472 class=n-a></a>No adverse effects.</td><td colspan=1 rowspan=2 valign=top><a name=d10682e1475 class=n-a></a>Promote neurite sprouting</td><td colspan=1 rowspan=1 valign=top><a name=d10682e1479 class=n-a></a><a href="#ref-127">127</a></td></tr><tr><a name=d10682e1483 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d10682e1485 class=n-a></a>ClinicalTrials.gov</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d10682e1492 class=n-a></a><p id=d10682e1493> The table lists the discussed neuroprotective strategies for spinal cord injury (SCI) undergoing clinical evaluation. The status of trials and enrollment information, including level of injury and results, are summarized. This demonstrates that clinical trials are predominately focused on cervical SCI.</p><p id=d10682e1496>Est, estimated; N/A, not applicable; MPSS, methylprednisolone sodium succinate.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10682e1504>Neuroprotective strategies in current care</h2><div class=section><a name=d10682e1507 class=n-a></a><h3 class=section-title>Early surgical decompression</h3><p class="" id=d10682e1512>The popularized phrase coined by the senior author, “Time is spine”, highlights the preclinical<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup> and clinical<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup> success of early surgical decompression, which aims to realign the spinal column and relieve bony or ligamentous spinal cord compression. Decompression of intradural pressure, by durotomy alone or durotomy combined with duraplasty, has also been evaluated in experimental SCI<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>. Yet mixed results warrant further research on the efficacy and standardization of these practices. In contrast, early extradural surgical decompression has been shown to reduce tissue damage and improve outcomes following SCI. Even with some concern regarding perioperative hemodynamic changes affecting cord perfusion, most spine surgeons have been, and continue to be, in favor of decompressing the acutely injured spinal cord<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. As a result, early decompression remains recommended in clinical management guidelines by the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons<sup><a href="#ref-21">21</a></sup>. Similarly, the recent AOSpine guideline also recommends decompression within 24 hours of SCI<sup><a href="#ref-22">22</a></sup>. While there may be differential efficacy between injury-level subpopulations<sup><a href="#ref-23">23</a></sup>, current evidence is limited by substantial clinical heterogeneity, loss to follow-up, unclear adjustment for baseline factors, and a lack of statistical power. For these reasons, more work is needed to develop customizable treatment regimens and prioritized surgical access to the most benefitting patient subtypes.</p></div><div class=section><a name=d10682e1557 class=n-a></a><h3 class=section-title>Support of mean arterial pressure</h3><p class="" id=d10682e1562>Hypotension, hypoxemia, pulmonary dysfunction, and cardiovascular instability are common within the first 7 to 10 days of SCI<sup><a href="#ref-24">24</a></sup>. Hemodynamic instability not only limits the opportunity for early surgical intervention but also increases spinal cord ischemia and therefore secondary damage. For this reason, the current AANS and Congress of Neurological Surgeons guideline recommends continuous hemodynamic monitoring, interventions correcting hypotension (such as by vasopressor administration), and maintenance of mean arterial blood pressure (MAP) between 85 and 90 mmHg for the first 7 days following cervical injury<sup><a href="#ref-25">25</a></sup>. While these recommendations are largely based on a small group of uncontrolled and underpowered studies<sup><a href="#ref-26">26</a></sup>, a recent retrospective assessment largely confirmed the published guidelines as well as the neuroprotective potential of vasopressor administration<sup><a href="#ref-27">27</a></sup>. As these results need further prospective validation, it will be important to stratify patient populations and identify potential treatment effect differences based on the anatomical level of injury. It is also important to note that MAP support principally aims to maintain appropriate spinal cord perfusion pressure (SCPP), determined by the difference between MAP and intraspinal pressure (ISP). However, as ISP may increase independently of MAP, maintenance of a low ISP or a high SCPP (or both) is gaining increasing attention as an important practice in the acute clinical management of SCI<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. While initial studies have shown encouraging results about the predictive value of low ISP or high SCPP in neurological recovery, larger multicenter studies are needed to validate these preliminary data<sup><a href="#ref-29">29</a></sup>.</p></div><div class=section><a name=d10682e1594 class=n-a></a><h3 class=section-title>Methylprednisolone sodium succinate</h3><p class="" id=d10682e1599>Methylprednisolone sodium succinate (MPSS) is a synthetic corticosteroid with potent anti-inflammatory effects and neuroprotective potential in acute traumatic SCI. Concerns about increased risk for infections following MPSS treatment have kept the drug at the forefront of continuous controversy. While it remains the only treatment option for acute SCI, debate regarding optimal dose, time of administration, efficacy, and adverse effects has dominated the field for decades and has dichotomized clinicians around the world. For this reason, there have been three National Acute Spinal Cord Injury Studies (NASCIS) to evaluate the clinical safety and efficacy of varying MPSS dose and timing. Moreover, NASCIS results have been retrospectively analyzed on numerous occasions to derive meaningful conclusions. One of the most recent publications on the topic concluded that MPSS does not increase the risk of infections and confers significant short-term effects when given within the first 8 hours of injury<sup><a href="#ref-30">30</a></sup>. Importantly, patients with cervical SCI and reduced baseline injury severity seem to benefit most from this treatment<sup><a href="#ref-31">31</a></sup>. Given the particularly debilitating nature of cervical injuries, these improvements have tremendous impact on patients’ quality of life. Thus, the most recent AOSpine guideline currently recommends a 24-hour treatment of intravenous MPSS when initiated within the first 8 hours of SCI, independently of injury level<sup><a href="#ref-22">22</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10682e1618>Promising neuroprotective and neural reparative therapies in clinical trials</h2><div class=section><a name=d10682e1621 class=n-a></a><h3 class=section-title>Riluzole</h3><p class="" id=d10682e1626>Secondary injury involves ionic dysregulation and excitotoxicity. As cell membranes become highly permeable to sodium ions, there is increased calcium influx. Subsequently, high sodium and calcium ion concentrations in neurons trigger the secretion of glutamate from nerve terminals. Increased synaptic glutamate leads to prolonged excitability in the postsynaptic neurons, driving eventual neuronal edema and death.</p><p class="" id=d10682e1629>Riluzole is a benzothiazole (molecular weight of 234.2 Da) which inhibits voltage-gated sodium channels and glutamate release, thereby mitigating excitotoxicity. Riluzole has been reported to slow the progression of amyotrophic lateral sclerosis (ALS)—a progressive motor neuron disease—and currently is the only US Food and Drug Administration (FDA)-approved drug for ALS. In addition, riluzole has been shown to have neuroprotective potential in animal models of Parkinson’s disease<sup><a href="#ref-32">32</a></sup> and Huntington’s disease<sup><a href="#ref-33">33</a></sup> and currently is being used in clinical studies of mild Alzheimer’s disease (ClinicalTrials.gov identifier NCT01703117). Importantly, riluzole was also shown to suppress spasticity<sup><a href="#ref-34">34</a></sup>, a frequent co-morbidity in patients with SCI, and to promote neural preservation in rats with high cervical spinal hemisection injury<sup><a href="#ref-35">35</a></sup>.</p><p class="" id=d10682e1648>Capitalizing on the preclinical success of riluzole, a phase I/IIA clinical trial was launched in April 2010 to assess the safety and pharmacokinetics of riluzole in patients with acute traumatic SCI (ClinicalTrials.gov identifier NCT00876889). In this trial, 36 patients with SCI (28 cervical and eight thoracic SCI) received riluzole (50 mg) orally every 12 hours for 28 doses. A control group consisting of 36 patients with SCI—matched for neurological impairment, gender, and age—received the standard of care but no riluzole. Patients who received riluzole showed statistically significant improvement compared with the control group (<i>P</i> = 0.021). In particular, patients with incomplete cervical injury—American Spinal Injury Association (ASIA) Impairment Scale B—showed the highest improvement in the International Standards for Neurologic Classification of Spinal Cord Injury (ISNCSCI) motor score (<i>P</i> = 0.037). In addition to being efficacious, riluzole was shown to be safe for this patient cohort<sup><a href="#ref-36">36</a></sup>. Interestingly, there was no difference within the thoracic injury group, as patient numbers were small, patients had more severe injuries, and the ISNCSCI motor scoring is less sensitive to thoracic recovery<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d10682e1665>Based on these results, a phase IIB/III was launched in 2013 to evaluate the efficacy and safety of riluzole in patients with cervical traumatic SCI, entitled “Riluzole in Acute SCI Study” (RISCIS) (estimated enrollment: 351 patients, ClinicalTrials.gov identifier NCT01597518). In this multicenter, randomized, placebo-controlled, double-blinded trial, riluzole (100 mg, twice daily) is administered orally to patients within 24 hours from injury, followed by two 50 mg daily doses for 14 days after SCI. A capsule identical in shape and size to riluzole is administered to patients in the control group. The primary outcome of the study is improvement in ISNCSCI motor scores at 180 days after injury. The study is estimated to be completed by 2021<sup><a href="#ref-37">37</a></sup>.</p></div><div class=section><a name=d10682e1673 class=n-a></a><h3 class=section-title>Therapeutic hypothermia</h3><p class="" id=d10682e1678>In response to trauma, increased metabolic rate can lead to excitotoxicity and cell death. Local or systemic cooling following insult has been shown to reduce the metabolic demand, thereby limiting cell death. Moreover, therapeutic hypothermia has been shown to reduce inflammatory cell infiltration, myeloperoxidase activity, and vasogenic edema and stabilize the blood-brain barrier<sup><a href="#ref-38">38</a></sup>. Despite these benefits, systemic hypothermia may have some serious side effects, including bradycardia, respiratory infections, and deep vein thrombosis. While local cooling of the spinal cord circumvents many of these concomitant issues, randomized controlled trials are still needed to prove the efficacy of local hypothermia in neurological recovery after SCI. However, in one study, acute (within 8 hours of injury) local hypothermia was shown to improve recovery among cervical and thoracic populations (n = 12 out of 14 cervical SCI, n = 4 out of 6 thoracic SCI) when compared with historical controls<sup><a href="#ref-39">39</a></sup>. Similarly, a pilot study of systemic hypothermia in patients with cervical complete SCI (n = 14) demonstrated fewer adverse effects and a trend toward improved recovery compared with age- and injury level-matched historical controls when systemic hypothermia was induced within 9 hours of trauma<sup><a href="#ref-40">40</a></sup>. Furthermore, a follow-up randomized controlled trial assessing the efficacy of intravascularly delivered systemic hypothermia in acute cervical SCI commenced in May 2017 (estimated enrollment: 120 patients, ClinicalTrials.gov identifier NCT02991690). Although previous multicenter randomized clinical trials found hypothermia to be ineffective in adults with traumatic brain injury<sup><a href="#ref-41">41</a></sup>, expectations for SCI remain hopeful.</p></div><div class=section><a name=d10682e1698 class=n-a></a><h3 class=section-title>Glibenclamide (Glyburide, DiaBeta)</h3><p class="" id=d10682e1703>Capillary fragmentation following SCI contributes to hemorrhage. This process is initiated in the capillary-rich gray matter of the injury epicenter and expands rostro-caudally, leading to progressive tissue necrosis, cavitation, and neurological dysfunction. In a rat model of unilateral cervical SCI, Simard <i>et al</i>. found that sulfonylurea receptor 1 (SUR1)-regulated Ca<sup>2+</sup>-activated [ATP]<sub>i</sub>-sensitive non-specific cation (NC<sub>Ca-ATP</sub>) channels of the capillary endothelium in the spinal cord are key to capillary fragmentation following SCI<sup><a href="#ref-42">42</a></sup>. By blocking NC<sub>Ca-ATP</sub> channels with the FDA-approved anti-diabetic drug glibenclamide (Glyburide), Simard <i>et al</i>. observed decreased lesion volumes and significant white matter preservation coupled with improved neurobehavioral outcomes<sup><a href="#ref-42">42</a></sup>. Recently, a phase I/II clinical trial was initiated to assess the safety and neuroprotective effectiveness of Glyburide (DiaBeta) in patients with acute traumatic cervical SCI (estimated enrollment: 10 patients, ClinicalTrials.gov identifier NCT02524379), with an estimated completion date in early 2020.</p></div><div class=section><a name=d10682e1734 class=n-a></a><h3 class=section-title>Granulocyte colony-stimulating factor</h3><p class="" id=d10682e1739>Initially overlooked for its potential in the central nervous system (CNS), granulocyte colony-stimulating factor (G-CSF) has shown positive preclinical results for SCI (<a href="#T1">Table 1</a>). In response to ischemia and CNS injury, G-CSF and its receptor (CD114; G-CSFR) are upregulated in neurons and endogenous stem cells, initiating a compensatory neuroprotective mechanism. By binding to its cognate receptor, G-CSF counteracts programmed cell death in mature neurons, induces neurogenesis, and promotes neuronal differentiation of adult neural stem cells<sup><a href="#ref-43">43</a></sup>. Moreover, angiogenesis<sup><a href="#ref-44">44</a></sup> and reduced inflammation<sup><a href="#ref-45">45</a></sup> have been attributed to the protective actions of G-CSF. Kamiya <i>et al</i>. administered G-CSF for 5 consecutive days after cervical SCI and assessed ASIA motor scores 3 months later<sup><a href="#ref-46">46</a></sup>. The improvements were significant compared with historical controls of patients with cervical SCI receiving high-dose MPSS<sup><a href="#ref-46">46</a></sup>. In a study by Inada <i>et al</i>., patients with cervical SCI who received G-CSF demonstrated improved recovery compared with a non-treated group<sup><a href="#ref-47">47</a></sup>. However, the treatment was administered in an open-label and non-randomized fashion<sup><a href="#ref-47">47</a></sup>. Interestingly, in a study by Saberi <i>et al</i>., in which G-CSF was administered in patients with chronic SCI, significant motor and sensory recovery was demonstrated, particularly in patients with incomplete cervical SCI<sup><a href="#ref-48">48</a></sup>. Despite these promising effects, a true double-blinded randomized control clinical trial for G-CSF has yet to be developed.</p></div><div class=section><a name=d10682e1790 class=n-a></a><h3 class=section-title>Minocycline</h3><p class="" id=d10682e1795>Inflammatory cytokines produced by resident microglia and astrocytes following trauma attract peripheral immune cells to the spinal cord. Neutrophils and monocytes are the first blood-derived cells to enter the injured parenchyma. While these cells are crucial in cleaning up the cellular debris, they produce inflammatory cytokines, such as tumor necrosis factor-alpha and interferon-gamma, as well as toxic by-products that exacerbate damage.</p><p class="" id=d10682e1798>Minocycline is a tetracycline antibiotic with neuroprotective and anti-inflammatory properties. A single-center, placebo-controlled, double-blinded phase I/II clinical trial was initiated in 2004 to evaluate the efficacy and safety of intravenous minocycline within 12 hours of injury for 7 days. The study, which was completed in 2010 (27 patients received minocycline and 25 received placebo), showed a trend toward improved motor scores in incomplete cervical SCI cases in the absence of any serious adverse effects (<i>P</i> = 0.05) but no improvement in thoracic SCI<sup><a href="#ref-49">49</a></sup> (ClinicalTrials.gov identifier NCT00559494). Based on these results, a phase III clinical trial, titled “Minocycline in Acute Spinal Cord Injury (MASC)”, was initiated in 2013 and is expected to finish by 2018 (estimated enrollment: 248 patients, ClinicalTrials.gov identifier NCT01828203). Interestingly, a clinical trial evaluating the efficacy of minocycline in reducing neuropathic pain has been successfully completed, but the results have yet to be published (ClinicalTrials.gov identifier NCT01869907). Given that neuropathic pain is a common and debilitating co-morbidity in patients with SCI, the study results will be of significant interest to the field.</p></div><div class=section><a name=d10682e1809 class=n-a></a><h3 class=section-title>Cethrin (VX-210)</h3><p class="" id=d10682e1814>The injured spinal cord niche contains growth-inhibitory molecules, such as myelin debris and chondroitin sulfate proteoglycans, that lead to neuron growth cone collapse, thereby inhibiting regeneration. These molecules bind to respective receptors on regenerating neurons, where they initiate a phosphorylation cascade. At the converging point of this cascade are Rho GTPases, a family of intracellular enzymes that regulate cytoskeletal mechanisms and cellular mobility. Cethrin (VX-210) is a recombinant deactivator of RhoA (a member of the Rho family) with dura and cell membrane penetrance. An open-label uncontrolled phase I/IIa clinical trial showed significant neurological improvement in patients with SCI who received Cethrin (48 patients, ClinicalTrials.gov identifier NCT00500812). Benefits were particularly enhanced in patients with cervical SCI compared with their thoracic counterparts<sup><a href="#ref-50">50</a></sup>, a finding that incentivized the initiation of larger controlled double-blinded clinical trials for patients with cervical SCI. This phase IIb/III clinical trial will evaluate the safety and efficacy of two doses of VX-210 (formerly known as Cethrin) compared with placebo (a fibrin sealant) when applied extradurally at the site of injury, acutely after cervical SCI (estimated enrollment: 150 patients, ClinicalTrials.gov identifier NCT02669849).</p></div><div class=section><a name=d10682e1822 class=n-a></a><h3 class=section-title>Anti-Nogo-A antibody (ATI-355)</h3><p class="" id=d10682e1827>Anti-Nogo-A antibody is a monoclonal antibody against Nogo-A, a protein inhibitor of neurite growth found on adult CNS myelin. Widely assessed at the thoracic level in rodents<sup><a href="#ref-51">51</a>–<a href="#ref-53">53</a></sup>, in addition to several studies in primate models of cervical SCI<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>, anti-Nogo-A antibody has been shown to promote axonal sprouting and improve functional recovery following injury. A non-randomized, open-label phase I clinical trial of humanized anti-Nogo-A antibody (ATI-355; Novartis Pharmaceuticals) was initiated to assess the feasibility, tolerability, and safety of either repeated intrathecal bolus injections of AT1-355 or continuous intrathecal delivery in acute SCI (4–14 days after injury). In total, 52 cervical and thoracic patients with traumas between C5 and T12 level were recruited in the study, and results are pending dissemination (ClinicalTrials.gov identifier NCT00406016). A phase IIb trial, led by Armin Curt, is expected to begin in Europe shortly.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10682e1848>Emerging neuroprotective approaches</h2><div class=section><a name=d10682e1851 class=n-a></a><h3 class=section-title>Intravenous immunoglobulin G</h3><p class="" id=d10682e1856>Intravenous immunoglobulin G (IVIG) consists of serum immunoglobulin G (IgG) pooled from thousands of healthy donors. Independent laboratory studies in cervical and thoracic models of SCI have shown that IVIG improves recovery by targeting the detrimental inflammatory response in the spinal cord after trauma<sup><a href="#ref-56">56</a>–<a href="#ref-58">58</a></sup>. While the efficacy of IVIG for SCI has not been assessed in clinical trials, the exciting preclinical results coupled with IVIG’s long-term clinical use for the treatment of autoimmune and immunodeficiency conditions make it a promising candidate for SCI clinical trials.</p></div><div class=section><a name=d10682e1867 class=n-a></a><h3 class=section-title>Cell therapies</h3><p class="" id=d10682e1872>With cell transplantation as an attractive treatment approach for SCI, a diverse range of cells has been evaluated in preclinical studies, resulting in a plethora of potential mechanisms. In short, transplanted cells have been used for immune modulation, trophic support, scaffolding, re-myelination, and cell replacement<sup><a href="#ref-59">59</a></sup>. Yet, predominantly applied in the subacute and chronic phases of injury, only a few cell transplantation strategies are thought to have neuroprotective potential for the acutely injured spinal cord.</p><p class="" id=d10682e1879> <b> <i>Mesenchymal stem/stromal cells.</i> </b> Mesenchymal stem/stromal cells (MSCs) are multipotent mesodermal progenitors defined by their <i>in vitro</i> adhesion to plastic and their cell surface antigen profile<sup><a href="#ref-60">60</a></sup>. Readily accessible from various adult tissues such as bone marrow, cartilage, and fat, MSCs are among the most commonly studied cells in regenerative medicine. This popularity has led to significant heterogeneity in MSC isolation, cultivation, and purification procedures, further resulting in mixed therapeutic efficacy among preclinical studies and the increasing number of clinical studies<sup><a href="#ref-61">61</a></sup>. In SCI, MSCs have been reported to dampen inflammation, modulate the immune response, and secrete neuroprotective factors<sup><a href="#ref-59">59</a></sup>. A 2013 systematic meta-analysis of preclinical studies, involving intrathecal, intraparenchymal, and intravenous infusion of MSCs in various models of cervical and thoracic SCI, determined that the cells, overall, result in improved functional recovery after injury<sup><a href="#ref-62">62</a></sup>. While this is encouraging, a lot remains to be understood about the identity and function of MSCs. Furthermore, additional mechanistic studies are needed to effectively tailor their therapeutic application for SCI and identify differences in efficacy between anatomical levels of injury.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10682e1912>Final thoughts</h2><p class="" id=d10682e1915>Spinal cord level-dependent differences in vertebral structure, anatomy, and peripheral immune organ innervation may affect SCI pathophysiology. Though largely overlooked in preclinical studies, post hoc subgroup analysis from seminal large-scale clinical trials has been indicative of varying treatment efficacy between different anatomical levels of SCI<sup><a href="#ref-50">50</a>,<a href="#ref-63">63</a></sup>. As a result, the stratification of patients into injury-level subpopulations is being increasingly adopted in trial design, and the aforementioned RISCIS trial is a leading example<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d10682e1929>Notwithstanding its strengths, this approach has considerable challenges. Firstly, given the clinical heterogeneity of SCI pathophysiology, even within the same level of injury, the recruitment of adequate patient numbers to reach statistical power may prove substantially difficult, especially for acute and infrequent injuries. Although multicenter trials may circumvent this issue, they require tremendous coordination, collaboration, and resources. However, a recently published assessment of patient recruitment for acute SCI trials determined that such multicenter Canadian trials are feasible with careful <i>a priori</i> planning and registry support<sup><a href="#ref-64">64</a></sup>. Secondly, stratified analysis is susceptible to confounding effects. For instance, treatment efficacy may be directly affected by patient age or injury causation rather than the anatomical level of injury<sup><a href="#ref-3">3</a></sup>. In addition, stratification according to injury level alone is unlikely to account for the significant variability in injury severity, presentation, and patient characteristics. Finally, a greater understanding of the impact of trauma-related mechanisms on the impact and outcomes of SCI is also required.</p><p class="" id=d10682e1943>Therefore, it is increasingly recognized that optimal patient recovery will stem from a combinatorial treatment regimen of integrated pharmacological and rehabilitation-based strategies that will be personalized to their SCI signature (age, medical history, level, completeness, and mechanism of injury). For this reason, translational laboratory studies need to compare neuroprotective efficacy, as well as combinatorial approaches, between different anatomical levels of injury and severity. Moreover, advances in imaging and biochemical biomarkers are needed to help tailor trials within a heterogeneous SCI patient population, narrowing the inclusion window and increasing study power. These approaches can be further applied to better assess treatment efficacy, specifically beyond basic neurological recovery. Apart from outcomes, treatment protocols should ensure sufficient drug delivery to target sites, especially for systemically administered neuroprotective agents with CNS-specific effects<sup><a href="#ref-65">65</a></sup>. Moreover, coordinated efforts should be made by leading SCI care units to standardize early medical management<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup> and monitoring practices<sup><a href="#ref-68">68</a></sup> in order to maximize the efficacy of randomized controlled trials. Lastly, with the increasing incidence of traumatic SCI in the elderly<sup><a href="#ref-3">3</a></sup>, it is important that more emphasis be placed on optimizing such practices to address the specific needs of this growing demographic.</p><p class="" id=d10682e1965>In conclusion, neuroprotection has the potential to improve recovery of motor, sensory, and autonomic function following SCI. Significant strides in our understanding of SCI pathophysiology, patient presentation, and biomarkers will further align preclinical research with clinical reality, yielding translatable solutions that can benefit patients.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d10682e1 class=n-a></a><h2 class=main-title id=d11074>Competing interests</h2><p class=metadata-entry><a name=d10682e136 class=n-a></a><p id=d10682e138> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d10682e1 class=n-a></a><h2 class=main-title id=d11076>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d10682e1972 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d11489>References</h2><div class="section ref-list"><a name=d10682e1972 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d10682e1979 class=n-a></a>Blesch A, Tuszynski MH: Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. <i>Trends Neurosci.</i> 2009; <b>32</b>(1): 41–7. <a target=xrefwindow id=d10682e1987 href="http://www.ncbi.nlm.nih.gov/pubmed/18977039">PubMed Abstract </a> | <a target=xrefwindow id=d10682e1990 href="http://dx.doi.org/10.1016/j.tins.2008.09.008">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d10682e1999 class=n-a></a>Kwon BK, Hillyer J, Tetzlaff W: Translational research in spinal cord injury: a survey of opinion from the SCI community. <i>J Neurotrauma.</i> 2010; <b>27</b>(1): 21–33. <a target=xrefwindow id=d10682e2007 href="http://www.ncbi.nlm.nih.gov/pubmed/19751098">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2010 href="http://dx.doi.org/10.1089/neu.2009.1048">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d10682e2019 class=n-a></a>Singh A, Tetreault L, Kalsi-Ryan S, <i> et al.</i>: Global prevalence and incidence of traumatic spinal cord injury. <i>Clin Epidemiol.</i> 2014; <b>6</b>: 309–31. <a target=xrefwindow id=d10682e2030 href="http://www.ncbi.nlm.nih.gov/pubmed/25278785">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2033 href="http://dx.doi.org/10.2147/CLEP.S68889">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2037 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4179833">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d10682e2046 class=n-a></a>Kameyama T, Hashizume Y, Sobue G: Morphologic features of the normal human cadaveric spinal cord. <i>Spine (Phila Pa 1976).</i> 1996; <b>21</b>(11): 1285–90. <a target=xrefwindow id=d10682e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/8725917">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2057 href="http://dx.doi.org/10.1097/00007632-199606010-00001">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727567332"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2066 class=n-a></a>Li Y, Lucas-Osma AM, Black S, <i> et al.</i>: Pericytes impair capillary blood flow and motor function after chronic spinal cord injury. <i>Nat Med.</i> 2017; <b>23</b>(6): 733–41. <a target=xrefwindow id=d10682e2077 href="http://www.ncbi.nlm.nih.gov/pubmed/28459438">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2080 href="http://dx.doi.org/10.1038/nm.4331">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727567332">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d10682e2094 class=n-a></a>Winkler EA, Sengillo JD, Bell RD, <i> et al.</i>: Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. <i>J Cereb Blood Flow Metab.</i> 2012; <b>32</b>(10): 1841–52. <a target=xrefwindow id=d10682e2105 href="http://www.ncbi.nlm.nih.gov/pubmed/22850407">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2108 href="http://dx.doi.org/10.1038/jcbfm.2012.113">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2112 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3463878">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d10682e2121 class=n-a></a>McKinley W, Santos K, Meade M, <i> et al.</i>: Incidence and outcomes of spinal cord injury clinical syndromes. <i>J Spinal Cord Med.</i> 2007; <b>30</b>(3): 215–24. <a target=xrefwindow id=d10682e2132 href="http://www.ncbi.nlm.nih.gov/pubmed/17684887">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2135 href="http://dx.doi.org/10.1080/10790268.2007.11753929">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2139 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2031952">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d10682e2148 class=n-a></a>Nouri A, Tetreault L, Singh A, <i> et al.</i>: Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis. <i>Spine (Phila Pa 1976).</i> 2015; <b>40</b>(12): E675–93. <a target=xrefwindow id=d10682e2159 href="http://www.ncbi.nlm.nih.gov/pubmed/25839387">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2162 href="http://dx.doi.org/10.1097/BRS.0000000000000913">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726070207"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2171 class=n-a></a>Brommer B, Engel O, Kopp MA, <i> et al.</i>: Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level. <i>Brain.</i> 2016; <b>139</b>(Pt 3): 692–707. <a target=xrefwindow id=d10682e2182 href="http://www.ncbi.nlm.nih.gov/pubmed/26754788">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2185 href="http://dx.doi.org/10.1093/brain/awv375">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2189 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5014125">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726070207">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d10682e2202 class=n-a></a>Lucin KM, Sanders VM, Jones TB, <i> et al.</i>: Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. <i>Exp Neurol.</i> 2007; <b>207</b>(1): 75–84. <a target=xrefwindow id=d10682e2213 href="http://www.ncbi.nlm.nih.gov/pubmed/17597612">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2216 href="http://dx.doi.org/10.1016/j.expneurol.2007.05.019">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2220 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2023967">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d10682e2229 class=n-a></a>Ibarra A, Jiménez A, Cortes C, <i> et al.</i>: Influence of the intensity, level and phase of spinal cord injury on the proliferation of T cells and T-cell-dependent antibody reactions in rats. <i>Spinal Cord.</i> 2007; <b>45</b>(5): 380–6. <a target=xrefwindow id=d10682e2240 href="http://www.ncbi.nlm.nih.gov/pubmed/16955070">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2243 href="http://dx.doi.org/10.1038/sj.sc.3101972">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d10682e2253 class=n-a></a>Ulndreaj A, Tzekou A, Mothe AJ, <i> et al.</i>: Characterization of the Antibody Response after Cervical Spinal Cord Injury. <i>J Neurotrauma.</i> 2017; <b>34</b>(6): 1209–26. <a target=xrefwindow id=d10682e2264 href="http://www.ncbi.nlm.nih.gov/pubmed/27775474">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2267 href="http://dx.doi.org/10.1089/neu.2016.4498">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2271 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5359645">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d10682e2280 class=n-a></a>Batchelor PE, Wills TE, Skeers P, <i> et al.</i>: Meta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressure. <i>PLoS One.</i> 2013; <b>8</b>(8): e72659. <a target=xrefwindow id=d10682e2291 href="http://www.ncbi.nlm.nih.gov/pubmed/24009695">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2294 href="http://dx.doi.org/10.1371/journal.pone.0072659">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2298 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3751840">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d10682e2307 class=n-a></a>Fehlings MG, Perrin RG: The timing of surgical intervention in the treatment of spinal cord injury: a systematic review of recent clinical evidence. <i>Spine (Phila Pa 1976).</i> 2006; <b>31</b>(11 Suppl): S28–35; discussion S36. <a target=xrefwindow id=d10682e2315 href="http://www.ncbi.nlm.nih.gov/pubmed/16685233">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2318 href="http://dx.doi.org/10.1097/01.brs.0000217973.11402.7f">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724164869"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2327 class=n-a></a>Fehlings MG, Vaccaro A, Wilson JR, <i> et al.</i>: Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). <i>PLoS One.</i> 2012; <b>7</b>(2): e32037. <a target=xrefwindow id=d10682e2338 href="http://www.ncbi.nlm.nih.gov/pubmed/22384132">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2341 href="http://dx.doi.org/10.1371/journal.pone.0032037">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2345 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3285644">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724164869">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d10682e2358 class=n-a></a>Furlan JC, Noonan V, Cadotte DW, <i> et al.</i>: Timing of decompressive surgery of spinal cord after traumatic spinal cord injury: an evidence-based examination of pre-clinical and clinical studies. <i>J Neurotrauma.</i> 2011; <b>28</b>(8): 1371–99. <a target=xrefwindow id=d10682e2369 href="http://www.ncbi.nlm.nih.gov/pubmed/20001726">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2372 href="http://dx.doi.org/10.1089/neu.2009.1147">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2376 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3143409">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d10682e2385 class=n-a></a>Jalan D, Saini N, Zaidi M, <i> et al.</i>: Effects of early surgical decompression on functional and histological outcomes after severe experimental thoracic spinal cord injury. <i>J Neurosurg Spine.</i> 2017; <b>26</b>(1): 62–75. <a target=xrefwindow id=d10682e2396 href="http://www.ncbi.nlm.nih.gov/pubmed/27636866">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2399 href="http://dx.doi.org/10.3171/2016.6.SPINE16343">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d10682e2409 class=n-a></a>Smith JS, Anderson R, Pham T, <i> et al.</i>: Role of early surgical decompression of the intradural space after cervical spinal cord injury in an animal model. <i>J Bone Joint Surg Am.</i> 2010; <b>92</b>(5): 1206–14. <a target=xrefwindow id=d10682e2420 href="http://www.ncbi.nlm.nih.gov/pubmed/20439667">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2423 href="http://dx.doi.org/10.2106/JBJS.I.00740">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2427 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2859904">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d10682e2436 class=n-a></a>Fehlings MG, Rabin D, Sears W, <i> et al.</i>: Current practice in the timing of surgical intervention in spinal cord injury. <i>Spine (Phila Pa 1976).</i> 2010; <b>35</b>(21 Suppl): S166–73. <a target=xrefwindow id=d10682e2447 href="http://www.ncbi.nlm.nih.gov/pubmed/20881458">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2450 href="http://dx.doi.org/10.1097/BRS.0b013e3181f386f6">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d10682e2459 class=n-a></a>Wilson JR, Tetreault LA, Kwon BK, <i> et al.</i>: Timing of Decompression in Patients With Acute Spinal Cord Injury: A Systematic Review. <i>Global Spine Journal.</i> 2017; <b>7</b>(3 Suppl): 95S–115. <a target=xrefwindow id=d10682e2470 href="http://dx.doi.org/10.1177/2192568217701716">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d10682e2479 class=n-a></a>Resnick DK: Updated Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injury. <i>Neurosurgery.</i> 2013; <b>72 Suppl 2</b>: 1. <a target=xrefwindow id=d10682e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/23417171">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2490 href="http://dx.doi.org/10.1227/NEU.0b013e318276ee7e">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d10682e2499 class=n-a></a>Fehlings MG, Wilson JR, Tetreault LA, <i> et al.</i>: A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Use of Methylprednisolone Sodium Succinate. <i>Global Spine Journal.</i> 2017; <b>7</b>(3 Suppl): 203S–11S. <a target=xrefwindow id=d10682e2510 href="http://dx.doi.org/10.1177/2192568217703085">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d10682e2519 class=n-a></a>Samuel AM, Bohl DD, Basques BA, <i> et al.</i>: Analysis of Delays to Surgery for Cervical Spinal Cord Injuries. <i>Spine (Phila Pa 1976).</i> 2015; <b>40</b>(13): 992–1000. <a target=xrefwindow id=d10682e2530 href="http://www.ncbi.nlm.nih.gov/pubmed/25785963">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2533 href="http://dx.doi.org/10.1097/BRS.0000000000000883">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d10682e2543 class=n-a></a>Levi L, Wolf A, Belzberg H: Hemodynamic parameters in patients with acute cervical cord trauma: description, intervention, and prediction of outcome. <i>Neurosurgery.</i> 1993; <b>33</b>(6): 1007–16; discussion 1016–7. <a target=xrefwindow id=d10682e2551 href="http://www.ncbi.nlm.nih.gov/pubmed/8133985">PubMed Abstract </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d10682e2560 class=n-a></a>Ryken TC, Hurlbert RJ, Hadley MN, <i> et al.</i>: The acute cardiopulmonary management of patients with cervical spinal cord injuries. <i>Neurosurgery.</i> 2013; <b>72 Suppl 2</b>: 84–92. <a target=xrefwindow id=d10682e2571 href="http://www.ncbi.nlm.nih.gov/pubmed/23417181">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2574 href="http://dx.doi.org/10.1227/NEU.0b013e318276ee16">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d10682e2583 class=n-a></a>Vale FL, Burns J, Jackson AB, <i> et al.</i>: Combined medical and surgical treatment after acute spinal cord injury: results of a prospective pilot study to assess the merits of aggressive medical resuscitation and blood pressure management. <i>J Neurosurg.</i> 1997; <b>87</b>(2): 239–46. <a target=xrefwindow id=d10682e2594 href="http://www.ncbi.nlm.nih.gov/pubmed/9254087">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2597 href="http://dx.doi.org/10.3171/jns.1997.87.2.0239">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729188042"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2606 class=n-a></a>Hawryluk G, Whetstone W, Saigal R, <i> et al.</i>: Mean Arterial Blood Pressure Correlates with Neurological Recovery after Human Spinal Cord Injury: Analysis of High Frequency Physiologic Data. <i>J Neurotrauma.</i> 2015; <b>32</b>(24): 1958–67. <a target=xrefwindow id=d10682e2617 href="http://www.ncbi.nlm.nih.gov/pubmed/25669633">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2620 href="http://dx.doi.org/10.1089/neu.2014.3778">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2624 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4677564">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729188042">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d10682e2637 class=n-a></a>Chen K, Marsh BC, Cowan M, <i> et al.</i>: Sequential therapy of anti-Nogo-A antibody treatment and treadmill training leads to cumulative improvements after spinal cord injury in rats. <i>Exp Neurol.</i> 2017; <b>292</b>: 135–44. <a target=xrefwindow id=d10682e2648 href="http://www.ncbi.nlm.nih.gov/pubmed/28341461">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2651 href="http://dx.doi.org/10.1016/j.expneurol.2017.03.012">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726995421"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2660 class=n-a></a>Saadoun S, Chen S, Papadopoulos MC: Intraspinal pressure and spinal cord perfusion pressure predict neurological outcome after traumatic spinal cord injury. <i>J Neurol Neurosurg Psychiatry.</i> 2017; <b>88</b>(5): 452–3. <a target=xrefwindow id=d10682e2668 href="http://www.ncbi.nlm.nih.gov/pubmed/27864426">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2671 href="http://dx.doi.org/10.1136/jnnp-2016-314600">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726995421">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725909206"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2685 class=n-a></a>Evaniew N, Belley-Côté EP, Fallah N, <i> et al.</i>: Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Systematic Review and Meta-Analysis. <i>J Neurotrauma.</i> 2016; <b>33</b>(5): 468–81. <a target=xrefwindow id=d10682e2696 href="http://www.ncbi.nlm.nih.gov/pubmed/26529320">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2699 href="http://dx.doi.org/10.1089/neu.2015.4192">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2703 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4779323">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725909206">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725552136"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2716 class=n-a></a>Evaniew N, Noonan VK, Fallah N, <i> et al.</i>: Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry. <i>J Neurotrauma.</i> 2015; <b>32</b>(21): 1674–83. <a target=xrefwindow id=d10682e2727 href="http://www.ncbi.nlm.nih.gov/pubmed/26065706">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2730 href="http://dx.doi.org/10.1089/neu.2015.3963">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2734 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4638202">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725552136">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d10682e2747 class=n-a></a>Fernandez-Espejo E: Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. <i>Mol Neurobiol.</i> 2004; <b>29</b>(1): 15–30. <a target=xrefwindow id=d10682e2755 href="http://www.ncbi.nlm.nih.gov/pubmed/15034220">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2758 href="http://dx.doi.org/10.1385/MN:29:1:15">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d10682e2767 class=n-a></a>Bonelli RM, Wenning GK, Kapfhammer HP: Huntington's disease: present treatments and future therapeutic modalities. <i>Int Clin Psychopharmacol.</i> 2004; <b>19</b>(2): 51–62. <a target=xrefwindow id=d10682e2775 href="http://www.ncbi.nlm.nih.gov/pubmed/15076012">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2778 href="http://dx.doi.org/10.1097/00004850-200403000-00001">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d10682e2787 class=n-a></a>Kitzman PH: Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat. <i>Neurosci Lett.</i> 2009; <b>455</b>(2): 150–3. <a target=xrefwindow id=d10682e2795 href="http://www.ncbi.nlm.nih.gov/pubmed/19368865">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2798 href="http://dx.doi.org/10.1016/j.neulet.2009.03.016">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d10682e2807 class=n-a></a>Satkunendrarajah K, Nassiri F, Karadimas SK, <i> et al.</i>: Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection. <i>Exp Neurol.</i> 2016; <b>276</b>: 59–71. <a target=xrefwindow id=d10682e2818 href="http://www.ncbi.nlm.nih.gov/pubmed/26394202">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2821 href="http://dx.doi.org/10.1016/j.expneurol.2015.09.011">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d10682e2831 class=n-a></a>Grossman RG, Fehlings MG, Frankowski RF, <i> et al.</i>: A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. <i>J Neurotrauma.</i> 2014; <b>31</b>(3): 239–55. <a target=xrefwindow id=d10682e2842 href="http://www.ncbi.nlm.nih.gov/pubmed/23859435">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2845 href="http://dx.doi.org/10.1089/neu.2013.2969">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2849 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3904533">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d10682e2858 class=n-a></a>Fehlings MG, Nakashima H, Nagoshi N, <i> et al.</i>: Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. <i>Spinal Cord.</i> 2016; <b>54</b>(1): 8–15. <a target=xrefwindow id=d10682e2869 href="http://www.ncbi.nlm.nih.gov/pubmed/26099215">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2872 href="http://dx.doi.org/10.1038/sc.2015.95">Publisher Full Text </a> | <a target=xrefwindow id=d10682e2876 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5399137">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727282127"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2885 class=n-a></a>Martirosyan NL, Patel AA, Carotenuto A, <i> et al.</i>: The role of therapeutic hypothermia in the management of acute spinal cord injury. <i>Clin Neurol Neurosurg.</i> 2017; <b>154</b>: 79–88. <a target=xrefwindow id=d10682e2896 href="http://www.ncbi.nlm.nih.gov/pubmed/28131967">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2899 href="http://dx.doi.org/10.1016/j.clineuro.2017.01.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727282127">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d10682e2912 class=n-a></a>Hansebout RR, Hansebout CR: Local cooling for traumatic spinal cord injury: outcomes in 20 patients and review of the literature. <i>J Neurosurg Spine.</i> 2014; <b>20</b>(5): 550–61. <a target=xrefwindow id=d10682e2920 href="http://www.ncbi.nlm.nih.gov/pubmed/24628130">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2923 href="http://dx.doi.org/10.3171/2014.2.SPINE13318">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d10682e2932 class=n-a></a>Levi AD, Casella G, Green BA, <i> et al.</i>: Clinical outcomes using modest intravascular hypothermia after acute cervical spinal cord injury. <i>Neurosurgery.</i> 2010; <b>66</b>(4): 670–7. <a target=xrefwindow id=d10682e2943 href="http://www.ncbi.nlm.nih.gov/pubmed/20190669">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2946 href="http://dx.doi.org/10.1227/01.NEU.0000367557.77973.5F">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d10682e2955 class=n-a></a>Clifton GL, Miller ER, Choi SC, <i> et al.</i>: Lack of effect of induction of hypothermia after acute brain injury. <i>N Engl J Med.</i> 2001; <b>344</b>(8): 556–63. <a target=xrefwindow id=d10682e2966 href="http://www.ncbi.nlm.nih.gov/pubmed/11207351">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2969 href="http://dx.doi.org/10.1056/NEJM200102223440803">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732024353"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e2979 class=n-a></a>Simard JM, Tsymbalyuk O, Ivanov A, <i> et al.</i>: Endothelial sulfonylurea receptor 1-regulated NC<sub>Ca-ATP</sub> channels mediate progressive hemorrhagic necrosis following spinal cord injury. <i>J Clin Invest.</i> 2007; <b>117</b>(8): 2105–13. <a target=xrefwindow id=d10682e2993 href="http://www.ncbi.nlm.nih.gov/pubmed/17657312">PubMed Abstract </a> | <a target=xrefwindow id=d10682e2997 href="http://dx.doi.org/10.1172/JCI32041">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3000 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1924498">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732024353">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d10682e3013 class=n-a></a>Schneider A, Krüger C, Steigleder T, <i> et al.</i>: The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. <i>J Clin Invest.</i> 2005; <b>115</b>(8): 2083–98. <a target=xrefwindow id=d10682e3024 href="http://www.ncbi.nlm.nih.gov/pubmed/16007267">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3027 href="http://dx.doi.org/10.1172/JCI23559">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3031 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1172228">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726346680"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3040 class=n-a></a>Kawabe J, Koda M, Hashimoto M, <i> et al.</i>: Neuroprotective effects of granulocyte colony-stimulating factor and relationship to promotion of angiogenesis after spinal cord injury in rats: laboratory investigation. <i>J Neurosurg Spine.</i> 2011; <b>15</b>(4): 414–21. <a target=xrefwindow id=d10682e3051 href="http://www.ncbi.nlm.nih.gov/pubmed/21721873">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3054 href="http://dx.doi.org/10.3171/2011.5.SPINE10421">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726346680">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d10682e3067 class=n-a></a>Hartung T: Anti-inflammatory effects of granulocyte colony-stimulating factor. <i>Curr Opin Hematol.</i> 1998; <b>5</b>(3): 221–5. <a target=xrefwindow id=d10682e3075 href="http://www.ncbi.nlm.nih.gov/pubmed/9664164">PubMed Abstract </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718468362"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3084 class=n-a></a>Kamiya K, Koda M, Furuya T, <i> et al.</i>: Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control. <i>Eur Spine J.</i> 2015; <b>24</b>(5): 963–7. <a target=xrefwindow id=d10682e3095 href="http://www.ncbi.nlm.nih.gov/pubmed/24961222">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3098 href="http://dx.doi.org/10.1007/s00586-014-3373-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718468362">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d10682e3111 class=n-a></a>Inada T, Takahashi H, Yamazaki M, <i> et al.</i>: Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year. <i>Spine (Phila Pa 1976).</i> 2014; <b>39</b>(3): 213–9. <a target=xrefwindow id=d10682e3122 href="http://www.ncbi.nlm.nih.gov/pubmed/24299727">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3125 href="http://dx.doi.org/10.1097/BRS.0000000000000121">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d10682e3135 class=n-a></a>Saberi H, Derakhshanrad N, Yekaninejad MS: Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study. <i>Cell Transplant.</i> 2014; <b>23 Suppl 1</b>: S19–23. <a target=xrefwindow id=d10682e3143 href="http://www.ncbi.nlm.nih.gov/pubmed/25302604">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3146 href="http://dx.doi.org/10.3727/096368914X684943">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720473514"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3155 class=n-a></a>Casha S, Zygun D, McGowan MD, <i> et al.</i>: Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. <i>Brain.</i> 2012; <b>135</b>(Pt 4): 1224–36. <a target=xrefwindow id=d10682e3166 href="http://www.ncbi.nlm.nih.gov/pubmed/22505632">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3169 href="http://dx.doi.org/10.1093/brain/aws072">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720473514">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d10682e3182 class=n-a></a>Fehlings MG, Theodore N, Harrop J, <i> et al.</i>: A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. <i>J Neurotrauma.</i> 2011; <b>28</b>(5): 787–96. <a target=xrefwindow id=d10682e3193 href="http://www.ncbi.nlm.nih.gov/pubmed/21381984">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3196 href="http://dx.doi.org/10.1089/neu.2011.1765">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d10682e3205 class=n-a></a>Bregman BS, Kunkel-Bagden E, Schnell L, <i> et al.</i>: Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. <i>Nature.</i> 1995; <b>378</b>(6556): 498–501. <a target=xrefwindow id=d10682e3216 href="http://www.ncbi.nlm.nih.gov/pubmed/7477407">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3219 href="http://dx.doi.org/10.1038/378498a0">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d10682e3228 class=n-a></a>Merkler D, Metz GA, Raineteau O, <i> et al.</i>: Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. <i>J Neurosci.</i> 2001; <b>21</b>(10): 3665–73. <a target=xrefwindow id=d10682e3239 href="http://www.ncbi.nlm.nih.gov/pubmed/11331396">PubMed Abstract </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d10682e3248 class=n-a></a>Schnell L, Schwab ME: Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. <i>Nature.</i> 1990; <b>343</b>(6255): 269–72. <a target=xrefwindow id=d10682e3256 href="http://www.ncbi.nlm.nih.gov/pubmed/2300171">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3259 href="http://dx.doi.org/10.1038/343269a0">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1040482"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3269 class=n-a></a>Freund P, Schmidlin E, Wannier T, <i> et al.</i>: Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. <i>Nat Med.</i> 2006; <b>12</b>(7): 790–2. <a target=xrefwindow id=d10682e3280 href="http://www.ncbi.nlm.nih.gov/pubmed/16819551">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3283 href="http://dx.doi.org/10.1038/nm1436">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1040482">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d10682e3296 class=n-a></a>Freund P, Wannier T, Schmidlin E, <i> et al.</i>: Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. <i>J Comp Neurol.</i> 2007; <b>502</b>(4): 644–59. <a target=xrefwindow id=d10682e3307 href="http://www.ncbi.nlm.nih.gov/pubmed/17394135">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3310 href="http://dx.doi.org/10.1002/cne.21321">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728465470"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3319 class=n-a></a>Brennan FH, Kurniawan ND, Vukovic J, <i> et al.</i>: IVIg attenuates complement and improves spinal cord injury outcomes in mice. <i>Ann Clin Transl Neurol.</i> 2016; <b>3</b>(7): 495–511. <a target=xrefwindow id=d10682e3330 href="http://www.ncbi.nlm.nih.gov/pubmed/27386499">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3333 href="http://dx.doi.org/10.1002/acn3.318">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3337 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4931715">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728465470">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d10682e3350 class=n-a></a>Gok B, Sciubba DM, Okutan O, <i> et al.</i>: Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G. <i>J Clin Neurosci.</i> 2009; <b>16</b>(4): 549–53. <a target=xrefwindow id=d10682e3361 href="http://www.ncbi.nlm.nih.gov/pubmed/19200733">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3364 href="http://dx.doi.org/10.1016/j.jocn.2008.04.024">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d10682e3373 class=n-a></a>Nguyen DH, Cho N, Satkunendrarajah K, <i> et al.</i>: Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. <i>J Neuroinflammation.</i> 2012; <b>9</b>: 224. <a target=xrefwindow id=d10682e3384 href="http://www.ncbi.nlm.nih.gov/pubmed/22998664">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3387 href="http://dx.doi.org/10.1186/1742-2094-9-224">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3391 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3503837">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d10682e3400 class=n-a></a>Badner A, Siddiqui AM, Fehlings MG: Spinal cord injuries: how could cell therapy help? <i>Expert Opin Biol Ther.</i> 2017; <b>17</b>(5): 529–41. <a target=xrefwindow id=d10682e3408 href="http://www.ncbi.nlm.nih.gov/pubmed/28306359">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3411 href="http://dx.doi.org/10.1080/14712598.2017.1308481">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13409148"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3421 class=n-a></a>Dominici M, Le Blanc K, Mueller I, <i> et al.</i>: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. <i>Cytotherapy.</i> 2006; <b>8</b>(4): 315–7. <a target=xrefwindow id=d10682e3432 href="http://www.ncbi.nlm.nih.gov/pubmed/16923606">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3435 href="http://dx.doi.org/10.1080/14653240600855905">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13409148">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725834233"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3448 class=n-a></a>Squillaro T, Peluso G, Galderisi U: Clinical Trials With Mesenchymal Stem Cells: An Update. <i>Cell Transplant.</i> 2016; <b>25</b>(5): 829–48. <a target=xrefwindow id=d10682e3456 href="http://www.ncbi.nlm.nih.gov/pubmed/26423725">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3459 href="http://dx.doi.org/10.3727/096368915X689622">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725834233">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d10682e3472 class=n-a></a>Oliveri RS, Bello S, Biering-Sørensen F: Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: systematic review with meta-analyses of rat models. <i>Neurobiol Dis.</i> 2014; <b>62</b>: 338–53. <a target=xrefwindow id=d10682e3480 href="http://www.ncbi.nlm.nih.gov/pubmed/24148857">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3483 href="http://dx.doi.org/10.1016/j.nbd.2013.10.014">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d10682e3492 class=n-a></a>Rahimi-Movaghar V: Clinical trials for the treatment of spinal cord injury: cervical and lumbar enlargements versus thoracic area. <i>Brain.</i> 2009; <b>132</b>(Pt 7): e115; author reply e116. <a target=xrefwindow id=d10682e3500 href="http://www.ncbi.nlm.nih.gov/pubmed/19022857">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3503 href="http://dx.doi.org/10.1093/brain/awn282">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d10682e3512 class=n-a></a>Thibault-Halman G, Rivers CS, Bailey CS, <i> et al.</i>: Predicting Recruitment Feasibility for Acute Spinal Cord Injury Clinical Trials in Canada Using National Registry Data. <i>J Neurotrauma.</i> 2017; <b>34</b>(3): 599–606. <a target=xrefwindow id=d10682e3523 href="http://www.ncbi.nlm.nih.gov/pubmed/27627704">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3526 href="http://dx.doi.org/10.1089/neu.2016.4568">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726579570"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3535 class=n-a></a>Phang I, Zoumprouli A, Papadopoulos MC, <i> et al.</i>: Microdialysis to Optimize Cord Perfusion and Drug Delivery in Spinal Cord Injury. <i>Ann Neurol.</i> 2016; <b>80</b>(4): 522–31. <a target=xrefwindow id=d10682e3546 href="http://www.ncbi.nlm.nih.gov/pubmed/27463064">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3549 href="http://dx.doi.org/10.1002/ana.24750">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726579570">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d10682e3563 class=n-a></a>Fehlings MG, Cadotte DW, Fehlings LN: A series of systematic reviews on the treatment of acute spinal cord injury: a foundation for best medical practice. <i>J Neurotrauma.</i> 2011; <b>28</b>(8): 1329–33. <a target=xrefwindow id=d10682e3571 href="http://www.ncbi.nlm.nih.gov/pubmed/21651382">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3574 href="http://dx.doi.org/10.1089/neu.2011.1955">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3143392">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732024354"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3586 class=n-a></a>Fransen BL, Hosman AJ, van Middendorp JJ, <i> et al.</i>: Pre-hospital and acute management of traumatic spinal cord injury in the Netherlands: survey results urge the need for standardisation. <i>Spinal Cord.</i> 2016; <b>54</b>(1): 34–8. <a target=xrefwindow id=d10682e3597 href="http://www.ncbi.nlm.nih.gov/pubmed/26169166">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3600 href="http://dx.doi.org/10.1038/sc.2015.111">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732024354">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726822447"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3613 class=n-a></a>Saadoun S, Papadopoulos MC: Spinal cord injury: is monitoring from the injury site the future? <i>Crit Care.</i> 2016; <b>20</b>(1): 308. <a target=xrefwindow id=d10682e3621 href="http://www.ncbi.nlm.nih.gov/pubmed/27716379">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3624 href="http://dx.doi.org/10.1186/s13054-016-1490-3">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3627 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5050726">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726822447">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d10682e3640 class=n-a></a>Ates O, Cayli SR, Gurses I, <i> et al.</i>: Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury. <i>J Clin Neurosci.</i> 2007; <b>14</b>(7): 658–65. <a target=xrefwindow id=d10682e3651 href="http://www.ncbi.nlm.nih.gov/pubmed/17532502">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3654 href="http://dx.doi.org/10.1016/j.jocn.2006.03.023">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d10682e3663 class=n-a></a>Hachem LD, Mothe AJ, Tator CH: Evaluation of the effects of riluzole on adult spinal cord-derived neural stem/progenitor cells <i>in vitro</i> and <i>in vivo</i>. <i>Int J Dev Neurosci.</i> 2015; <b>47</b>(Pt B): 140–6. <a target=xrefwindow id=d10682e3677 href="http://www.ncbi.nlm.nih.gov/pubmed/26390954">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3681 href="http://dx.doi.org/10.1016/j.ijdevneu.2015.08.007">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d10682e3690 class=n-a></a>Hama A, Sagen J: Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain. <i>J Neurotrauma.</i> 2011; <b>28</b>(1): 127–34. <a target=xrefwindow id=d10682e3698 href="http://www.ncbi.nlm.nih.gov/pubmed/20954888">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3701 href="http://dx.doi.org/10.1089/neu.2010.1539">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d10682e3711 class=n-a></a>Mu X, Azbill RD, Springer JE: Riluzole improves measures of oxidative stress following traumatic spinal cord injury. <i>Brain Res.</i> 2000; <b>870</b>(1–2): 66–72. <a target=xrefwindow id=d10682e3719 href="http://www.ncbi.nlm.nih.gov/pubmed/10869502">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3722 href="http://dx.doi.org/10.1016/S0006-8993(00)02402-1">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d10682e3731 class=n-a></a>Stutzmann JM, Pratt J, Boraud T, <i> et al.</i>: The effect of riluzole on post-traumatic spinal cord injury in the rat. <i>Neuroreport.</i> 1996; <b>7</b>(2): 387–92. <a target=xrefwindow id=d10682e3742 href="http://www.ncbi.nlm.nih.gov/pubmed/8730788">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3745 href="http://dx.doi.org/10.1097/00001756-199601310-00003">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726334444"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3754 class=n-a></a>Vasconcelos NL, Gomes ED, Oliveira EP, <i> et al.</i>: Combining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury. <i>Spine J.</i> 2016; <b>16</b>(8): 1015–24. <a target=xrefwindow id=d10682e3765 href="http://www.ncbi.nlm.nih.gov/pubmed/27109831">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3768 href="http://dx.doi.org/10.1016/j.spinee.2016.04.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726334444">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725659022"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e3781 class=n-a></a>Hosier H, Peterson D, Tsymbalyuk O, <i> et al.</i>: A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury. <i>J Neurotrauma.</i> 2015; <b>32</b>(21): 1633–44. <a target=xrefwindow id=d10682e3792 href="http://www.ncbi.nlm.nih.gov/pubmed/26192071">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3795 href="http://dx.doi.org/10.1089/neu.2015.3892">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3799 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4638208">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725659022">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d10682e3812 class=n-a></a>Schwartz G, Fehlings MG: Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. <i>J Neurosurg.</i> 2001; <b>94</b>(2 Suppl): 245–56. <a target=xrefwindow id=d10682e3820 href="http://www.ncbi.nlm.nih.gov/pubmed/11302627">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3823 href="http://dx.doi.org/10.3171/spi.2001.94.2.0245">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d10682e3832 class=n-a></a>Simard JM, Tsymbalyuk O, Keledjian K, <i> et al.</i>: Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. <i>Exp Neurol.</i> 2012; <b>233</b>(1): 566–74. <a target=xrefwindow id=d10682e3843 href="http://www.ncbi.nlm.nih.gov/pubmed/22177998">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3846 href="http://dx.doi.org/10.1016/j.expneurol.2011.11.044">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3272255">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d10682e3860 class=n-a></a>Wu Y, Satkundrarajah K, Teng Y, <i> et al.</i>: Evaluation of the sodium-glutamate blocker riluzole in a preclinical model of ervical spinal cord injury. <i>Evid Based Spine Care J.</i> 2010; <b>1</b>(2): 71–2. <a target=xrefwindow id=d10682e3871 href="http://www.ncbi.nlm.nih.gov/pubmed/23637674">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3874 href="http://dx.doi.org/10.1055/s-0030-1267047">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3878 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3623105">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d10682e3887 class=n-a></a>Wu Y, Satkunendrarajah K, Teng Y, <i> et al.</i>: Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. <i>J Neurotrauma.</i> 2013; <b>30</b>(6): 441–52. <a target=xrefwindow id=d10682e3898 href="http://www.ncbi.nlm.nih.gov/pubmed/23517137">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3901 href="http://dx.doi.org/10.1089/neu.2012.2622">Publisher Full Text </a> | <a target=xrefwindow id=d10682e3905 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3696918">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d10682e3914 class=n-a></a>Batchelor PE, Kerr NF, Gatt AM, <i> et al.</i>: Hypothermia prior to decompression: buying time for treatment of acute spinal cord injury. <i>J Neurotrauma.</i> 2010; <b>27</b>(8): 1357–68. <a target=xrefwindow id=d10682e3925 href="http://www.ncbi.nlm.nih.gov/pubmed/20504158">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3928 href="http://dx.doi.org/10.1089/neu.2010.1360">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d10682e3937 class=n-a></a>Farooque M, Hillered L, Holtz A, <i> et al.</i>: Effects of moderate hypothermia on extracellular lactic acid and amino acids after severe compression injury of rat spinal cord. <i>J Neurotrauma.</i> 1997; <b>14</b>(1): 63–9. <a target=xrefwindow id=d10682e3948 href="http://www.ncbi.nlm.nih.gov/pubmed/9048312">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3951 href="http://dx.doi.org/10.1089/neu.1997.14.63">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d10682e3960 class=n-a></a>Grulova I, Slovinska L, Nagyova M, <i> et al.</i>: The effect of hypothermia on sensory-motor function and tissue sparing after spinal cord injury. <i>Spine J.</i> 2013; <b>13</b>(12): 1881–91. <a target=xrefwindow id=d10682e3971 href="http://www.ncbi.nlm.nih.gov/pubmed/24012427">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3974 href="http://dx.doi.org/10.1016/j.spinee.2013.06.073">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d10682e3983 class=n-a></a>Morino T, Ogata T, Takeba J, <i> et al.</i>: Microglia inhibition is a target of mild hypothermic treatment after the spinal cord injury. <i>Spinal Cord.</i> 2008; <b>46</b>(6): 425–31. <a target=xrefwindow id=d10682e3994 href="http://www.ncbi.nlm.nih.gov/pubmed/18317490">PubMed Abstract </a> | <a target=xrefwindow id=d10682e3997 href="http://dx.doi.org/10.1038/sj.sc.3102163">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d10682e4007 class=n-a></a>Seo JY, Kim YH, Kim JW, <i> et al.</i>: Effects of Therapeutic Hypothermia on Apoptosis and Autophagy After Spinal Cord Injury in Rats. <i>Spine (Phila Pa 1976).</i> 2015; <b>40</b>(12): 883–90. <a target=xrefwindow id=d10682e4018 href="http://www.ncbi.nlm.nih.gov/pubmed/25705963">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4021 href="http://dx.doi.org/10.1097/BRS.0000000000000845">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d10682e4030 class=n-a></a>Yu CG, Jimenez O, Marcillo AE, <i> et al.</i>: Beneficial effects of modest systemic hypothermia on locomotor function and histopathological damage following contusion-induced spinal cord injury in rats. <i>J Neurosurg.</i> 2000; <b>93</b>(1 Suppl): 85–93. <a target=xrefwindow id=d10682e4041 href="http://www.ncbi.nlm.nih.gov/pubmed/10879763">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4044 href="http://dx.doi.org/10.3171/spi.2000.93.1.0085">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725027185"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e4053 class=n-a></a>Lo TP Jr, Cho KS, Garg MS, <i> et al.</i>: Systemic hypothermia improves histological and functional outcome after cervical spinal cord contusion in rats. <i>J Comp Neurol.</i> 2009; <b>514</b>(5): 433–48. <a target=xrefwindow id=d10682e4064 href="http://www.ncbi.nlm.nih.gov/pubmed/19350644">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4067 href="http://dx.doi.org/10.1002/cne.22014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725027185">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d10682e4080 class=n-a></a>Redondo-Castro E, Hernández J, Mahy N, <i> et al.</i>: Phagocytic microglial phenotype induced by glibenclamide improves functional recovery but worsens hyperalgesia after spinal cord injury in adult rats. <i>Eur J Neurosci.</i> 2013; <b>38</b>(12): 3786–98. <a target=xrefwindow id=d10682e4091 href="http://www.ncbi.nlm.nih.gov/pubmed/24112298">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4094 href="http://dx.doi.org/10.1111/ejn.12382">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d10682e4103 class=n-a></a>Simard JM, Woo SK, Norenberg MD, <i> et al.</i>: Brief suppression of <i>Abcc8</i> prevents autodestruction of spinal cord after trauma. <i>Sci Transl Med.</i> 2010; <b>2</b>(28): 28ra29. <a target=xrefwindow id=d10682e4117 href="http://www.ncbi.nlm.nih.gov/pubmed/20410530">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4121 href="http://dx.doi.org/10.1126/scitranslmed.3000522">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4124 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2903041">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d10682e4133 class=n-a></a>Popovich PG, Lemeshow S, Gensel JC, <i> et al.</i>: Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injury. <i>Exp Neurol.</i> 2012; <b>233</b>(2): 615–22. <a target=xrefwindow id=d10682e4144 href="http://www.ncbi.nlm.nih.gov/pubmed/21145891">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4147 href="http://dx.doi.org/10.1016/j.expneurol.2010.11.016">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4151 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3272125">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d10682e4161 class=n-a></a>Simard JM, Popovich PG, Tsymbalyuk O, <i> et al.</i>: Spinal cord injury with unilateral versus bilateral primary hemorrhage--effects of glibenclamide. <i>Exp Neurol.</i> 2012; <b>233</b>(2): 829–35. <a target=xrefwindow id=d10682e4172 href="http://www.ncbi.nlm.nih.gov/pubmed/22197047">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4175 href="http://dx.doi.org/10.1016/j.expneurol.2011.11.048">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4179 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3272086">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d10682e4188 class=n-a></a>Simard JM, Popovich PG, Tsymbalyuk O, <i> et al.</i>: MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury. <i>Spinal Cord.</i> 2013; <b>51</b>(11): 823–7. <a target=xrefwindow id=d10682e4199 href="http://www.ncbi.nlm.nih.gov/pubmed/24042989">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4202 href="http://dx.doi.org/10.1038/sc.2013.99">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4206 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4076111">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d10682e4215 class=n-a></a>Chen WF, Chen CH, Chen NF, <i> et al.</i>: Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury. <i>CNS Neurosci Ther.</i> 2015; <b>21</b>(9): 698–707. <a target=xrefwindow id=d10682e4226 href="http://www.ncbi.nlm.nih.gov/pubmed/26190345">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4229 href="http://dx.doi.org/10.1111/cns.12429">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d10682e4238 class=n-a></a>Chung J, Kim MH, Yoon YJ, <i> et al.</i>: Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats. <i>J Neurosurg Spine.</i> 2014; <b>21</b>(6): 966–73. <a target=xrefwindow id=d10682e4249 href="http://www.ncbi.nlm.nih.gov/pubmed/25279652">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4252 href="http://dx.doi.org/10.3171/2014.8.SPINE131090">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d10682e4261 class=n-a></a>Dittgen T, Pitzer C, Plaas C, <i> et al.</i>: Granulocyte-colony stimulating factor (G-CSF) improves motor recovery in the rat impactor model for spinal cord injury. <i>PLoS One.</i> 2012; <b>7</b>(1): e29880. <a target=xrefwindow id=d10682e4272 href="http://www.ncbi.nlm.nih.gov/pubmed/22253813">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4275 href="http://dx.doi.org/10.1371/journal.pone.0029880">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4279 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3257226">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d10682e4288 class=n-a></a>Guo Y, Liu S, Zhang X, <i> et al.</i>: G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice. <i>Lab Invest.</i> 2015; <b>95</b>(12): 1439–49. <a target=xrefwindow id=d10682e4299 href="http://www.ncbi.nlm.nih.gov/pubmed/26524416">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4302 href="http://dx.doi.org/10.1038/labinvest.2015.120">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d10682e4312 class=n-a></a>Kadota R, Koda M, Kawabe J, <i> et al.</i>: Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats. <i>PLoS One.</i> 2012; <b>7</b>(11): e50391. <a target=xrefwindow id=d10682e4323 href="http://www.ncbi.nlm.nih.gov/pubmed/23209732">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4326 href="http://dx.doi.org/10.1371/journal.pone.0050391">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4330 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3507692">Free Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d10682e4339 class=n-a></a>Kato K, Koda M, Takahashi H, <i> et al.</i>: Granulocyte colony-stimulating factor attenuates spinal cord injury-induced mechanical allodynia in adult rats. <i>J Neurol Sci.</i> 2015; <b>355</b>(1–2): 79–83. <a target=xrefwindow id=d10682e4350 href="http://www.ncbi.nlm.nih.gov/pubmed/26055312">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4353 href="http://dx.doi.org/10.1016/j.jns.2015.05.024">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d10682e4362 class=n-a></a>Koda M, Nishio Y, Kamada T, <i> et al.</i>: Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. <i>Brain Res.</i> 2007; <b>1149</b>: 223–31. <a target=xrefwindow id=d10682e4373 href="http://www.ncbi.nlm.nih.gov/pubmed/17391650">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4376 href="http://dx.doi.org/10.1016/j.brainres.2007.02.058">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d10682e4385 class=n-a></a>Nishio Y, Koda M, Kamada T, <i> et al.</i>: Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. <i>J Neuropathol Exp Neurol.</i> 2007; <b>66</b>(8): 724–31. <a target=xrefwindow id=d10682e4396 href="http://www.ncbi.nlm.nih.gov/pubmed/17882016">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4399 href="http://dx.doi.org/10.1097/nen.0b013e3181257176">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d10682e4408 class=n-a></a>Pitzer C, Klussmann S, Krüger C, <i> et al.</i>: The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury. <i>J Neurochem.</i> 2010; <b>113</b>(4): 930–42. <a target=xrefwindow id=d10682e4419 href="http://www.ncbi.nlm.nih.gov/pubmed/20202082">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4422 href="http://dx.doi.org/10.1111/j.1471-4159.2010.06659.x">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d10682e4431 class=n-a></a>Sanli AM, Serbes G, Calişkan M, <i> et al.</i>: Effect of granulocyte-colony stimulating factor on spinal cord tissue after experimental contusion injury. <i>J Clin Neurosci.</i> 2010; <b>17</b>(12): 1548–52. <a target=xrefwindow id=d10682e4442 href="http://www.ncbi.nlm.nih.gov/pubmed/20801040">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4445 href="http://dx.doi.org/10.1016/j.jocn.2010.03.043">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d10682e4455 class=n-a></a>Urdzíková L, Jendelová P, Glogarová K, <i> et al.</i>: Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. <i>J Neurotrauma.</i> 2006; <b>23</b>(9): 1379–91. <a target=xrefwindow id=d10682e4466 href="http://www.ncbi.nlm.nih.gov/pubmed/16958589">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4469 href="http://dx.doi.org/10.1089/neu.2006.23.1379">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d10682e4478 class=n-a></a>Ahmad M, Zakaria A, Almutairi KM: Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats. <i>Pharmacol Biochem Behav.</i> 2016; <b>145</b>: 45–54. <a target=xrefwindow id=d10682e4486 href="http://www.ncbi.nlm.nih.gov/pubmed/27106204">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4489 href="http://dx.doi.org/10.1016/j.pbb.2016.04.003">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d10682e4498 class=n-a></a>Aras M, Altas M, Motor S, <i> et al.</i>: Protective effects of minocycline on experimental spinal cord injury in rats. <i>Injury.</i> 2015; <b>46</b>(8): 1471–4. <a target=xrefwindow id=d10682e4509 href="http://www.ncbi.nlm.nih.gov/pubmed/26052053">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4512 href="http://dx.doi.org/10.1016/j.injury.2015.05.018">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d10682e4521 class=n-a></a>Arnold SA, Hagg T: Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice. <i>J Neurotrauma.</i> 2011; <b>28</b>(9): 1995–2002. <a target=xrefwindow id=d10682e4529 href="http://www.ncbi.nlm.nih.gov/pubmed/21740131">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4532 href="http://dx.doi.org/10.1089/neu.2011.1888">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4535 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3172871">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/719059095"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e4544 class=n-a></a>Festoff BW, Ameenuddin S, Arnold PM, <i> et al.</i>: Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. <i>J Neurochem.</i> 2006; <b>97</b>(5): 1314–26. <a target=xrefwindow id=d10682e4555 href="http://www.ncbi.nlm.nih.gov/pubmed/16638021">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4558 href="http://dx.doi.org/10.1111/j.1471-4159.2006.03799.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/719059095">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d10682e4571 class=n-a></a>Lee SM, Yune TY, Kim SJ, <i> et al.</i>: Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. <i>J Neurotrauma.</i> 2003; <b>20</b>(10): 1017–27. <a target=xrefwindow id=d10682e4582 href="http://www.ncbi.nlm.nih.gov/pubmed/14588118 ">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4585 href="http://dx.doi.org/10.1089/089771503770195867">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d10682e4595 class=n-a></a>Marchand F, Tsantoulas C, Singh D, <i> et al.</i>: Effects of Etanercept and Minocycline in a rat model of spinal cord injury. <i>Eur J Pain.</i> 2009; <b>13</b>(7): 673–81. <a target=xrefwindow id=d10682e4606 href="http://www.ncbi.nlm.nih.gov/pubmed/18849175">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4609 href="http://dx.doi.org/10.1016/j.ejpain.2008.08.001">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d10682e4618 class=n-a></a>Sonmez E, Kabatas S, Ozen O, <i> et al.</i>: Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat. <i>Spine (Phila Pa 1976).</i> 2013; <b>38</b>(15): 1253–9. <a target=xrefwindow id=d10682e4629 href="http://www.ncbi.nlm.nih.gov/pubmed/23370685">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4632 href="http://dx.doi.org/10.1097/BRS.0b013e3182895587">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1160736"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e4641 class=n-a></a>Tan AM, Zhao P, Waxman SG, <i> et al.</i>: Early microglial inhibition preemptively mitigates chronic pain development after experimental spinal cord injury. <i>J Rehabil Res Dev.</i> 2009; <b>46</b>(1): 123–33. <a target=xrefwindow id=d10682e4652 href="http://www.ncbi.nlm.nih.gov/pubmed/19533525">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4655 href="http://dx.doi.org/10.1682/JRRD.2008.03.0048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1160736">F1000 Recommendation</a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d10682e4668 class=n-a></a>Teng YD, Choi H, Onario RC, <i> et al.</i>: Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. <i>Proc Natl Acad Sci U S A.</i> 2004; <b>101</b>(9): 3071–6. <a target=xrefwindow id=d10682e4679 href="http://www.ncbi.nlm.nih.gov/pubmed/14981254">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4682 href="http://dx.doi.org/10.1073/pnas.0306239101">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4686 href="http://www.ncbi.nlm.nih.gov/pmc/articles/365746">Free Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d10682e4695 class=n-a></a>Yune TY, Lee JY, Jung GY, <i> et al.</i>: Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. <i>J Neurosci.</i> 2007; <b>27</b>(29): 7751–61. <a target=xrefwindow id=d10682e4706 href="http://www.ncbi.nlm.nih.gov/pubmed/17634369">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4709 href="http://dx.doi.org/10.1523/JNEUROSCI.1661-07.2007">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d10682e4718 class=n-a></a>Stirling DP, Khodarahmi K, Liu J, <i> et al.</i>: Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. <i>J Neurosci.</i> 2004; <b>24</b>(9): 2182–90. <a target=xrefwindow id=d10682e4729 href="http://www.ncbi.nlm.nih.gov/pubmed/14999069">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4732 href="http://dx.doi.org/10.1523/JNEUROSCI.5275-03.2004">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726852325"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e4742 class=n-a></a>Wang Z, Nong J, Shultz RB, <i> et al.</i>: Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury. <i>Biomaterials.</i> 2017; <b>112</b>: 62–71. <a target=xrefwindow id=d10682e4753 href="http://www.ncbi.nlm.nih.gov/pubmed/27744221">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4756 href="http://dx.doi.org/10.1016/j.biomaterials.2016.10.002">Publisher Full Text </a> | <a target=xrefwindow id=d10682e4760 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5120994">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726852325">F1000 Recommendation</a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d10682e4773 class=n-a></a>Wells JE, Hurlbert RJ, Fehlings MG, <i> et al.</i>: Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. <i>Brain.</i> 2003; <b>126</b>(Pt 7): 1628–37. <a target=xrefwindow id=d10682e4784 href="http://www.ncbi.nlm.nih.gov/pubmed/12805103">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4787 href="http://dx.doi.org/10.1093/brain/awg178">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d10682e4796 class=n-a></a>Boato F, Hendrix S, Huelsenbeck SC, <i> et al.</i>: C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts. <i>J Cell Sci.</i> 2010; <b>123</b>(Pt 10): 1652–62. <a target=xrefwindow id=d10682e4807 href="http://www.ncbi.nlm.nih.gov/pubmed/20406886">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4810 href="http://dx.doi.org/10.1242/jcs.066050">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d10682e4819 class=n-a></a>Dergham P, Ellezam B, Essagian C, <i> et al.</i>: Rho signaling pathway targeted to promote spinal cord repair. <i>J Neurosci.</i> 2002; <b>22</b>(15): 6570–7. <a target=xrefwindow id=d10682e4830 href="http://www.ncbi.nlm.nih.gov/pubmed/12151536">PubMed Abstract </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d10682e4839 class=n-a></a>Fournier AE, Takizawa BT, Strittmatter SM: Rho kinase inhibition enhances axonal regeneration in the injured CNS. <i>J Neurosci.</i> 2003; <b>23</b>(4): 1416–23. <a target=xrefwindow id=d10682e4847 href="http://www.ncbi.nlm.nih.gov/pubmed/12598630">PubMed Abstract </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d10682e4856 class=n-a></a>Sung JK, Miao L, Calvert JW, <i> et al.</i>: A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. <i>Brain Res.</i> 2003; <b>959</b>(1): 29–38. <a target=xrefwindow id=d10682e4867 href="http://www.ncbi.nlm.nih.gov/pubmed/12480155">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4870 href="http://dx.doi.org/10.1016/S0006-8993(02)03717-4">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d10682e4880 class=n-a></a>Atalay B, Bavbek M, Cekinmez M, <i> et al.</i>: Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats. <i>Spinal Cord.</i> 2007; <b>45</b>(12): 780–6. <a target=xrefwindow id=d10682e4891 href="http://www.ncbi.nlm.nih.gov/pubmed/17724451">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4894 href="http://dx.doi.org/10.1038/sj.sc.3102113">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d10682e4903 class=n-a></a>Brösamle C, Huber AB, Fiedler M, <i> et al.</i>: Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. <i>J Neurosci.</i> 2000; <b>20</b>(21): 8061–8. <a target=xrefwindow id=d10682e4914 href="http://www.ncbi.nlm.nih.gov/pubmed/11050127">PubMed Abstract </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d10682e4923 class=n-a></a>Chen S, Smielewski P, Czosnyka M, <i> et al.</i>: Continuous Monitoring and Visualization of Optimum Spinal Cord Perfusion Pressure in Patients with Acute Cord Injury. <i>J Neurotrauma.</i> 2017; <b>34</b>(21): 2941–2949. <a target=xrefwindow id=d10682e4934 href="http://www.ncbi.nlm.nih.gov/pubmed/28351230">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4937 href="http://dx.doi.org/10.1089/neu.2017.4982">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d10682e4946 class=n-a></a>Fouad K, Klusman I, Schwab ME: Regenerating corticospinal fibers in the Marmoset (<i>Callitrix jacchus</i>) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. <i>Eur J Neurosci.</i> 2004; <b>20</b>(9): 2479–82. <a target=xrefwindow id=d10682e4957 href="http://www.ncbi.nlm.nih.gov/pubmed/15525289">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4960 href="http://dx.doi.org/10.1111/j.1460-9568.2004.03716.x">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d10682e4969 class=n-a></a>Gonzenbach RR, Zoerner B, Schnell L, <i> et al.</i>: Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness. <i>J Neurotrauma.</i> 2012; <b>29</b>(3): 567–78. <a target=xrefwindow id=d10682e4980 href="http://www.ncbi.nlm.nih.gov/pubmed/21815784">PubMed Abstract </a> | <a target=xrefwindow id=d10682e4983 href="http://dx.doi.org/10.1089/neu.2011.1752">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722952355"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10682e4992 class=n-a></a>Liebscher T, Schnell L, Schnell D, <i> et al.</i>: Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. <i>Ann Neurol.</i> 2005; <b>58</b>(5): 706–19. <a target=xrefwindow id=d10682e5003 href="http://www.ncbi.nlm.nih.gov/pubmed/16173073">PubMed Abstract </a> | <a target=xrefwindow id=d10682e5006 href="http://dx.doi.org/10.1002/ana.20627">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722952355">F1000 Recommendation</a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d10682e5020 class=n-a></a>Maier IC, Ichiyama RM, Courtine G, <i> et al.</i>: Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. <i>Brain.</i> 2009; <b>132</b>(Pt 6): 1426–40. <a target=xrefwindow id=d10682e5031 href="http://www.ncbi.nlm.nih.gov/pubmed/19372269">PubMed Abstract </a> | <a target=xrefwindow id=d10682e5034 href="http://dx.doi.org/10.1093/brain/awp085">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d10682e5043 class=n-a></a>Zörner B, Schwab ME: Anti-Nogo on the go: from animal models to a clinical trial. <i>Ann N Y Acad Sci.</i> 2010; <b>1198 Suppl 1</b>: E22–34. <a target=xrefwindow id=d10682e5051 href="http://www.ncbi.nlm.nih.gov/pubmed/20590535">PubMed Abstract </a> | <a target=xrefwindow id=d10682e5054 href="http://dx.doi.org/10.1111/j.1749-6632.2010.05566.x">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d10682e5063 class=n-a></a>Fawcett JW, Curt A, Steeves JD, <i> et al.</i>: Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. <i>Spinal Cord.</i> 2007; <b>45</b>(3): 190–205. <a target=xrefwindow id=d10682e5074 href="http://www.ncbi.nlm.nih.gov/pubmed/17179973">PubMed Abstract </a> | <a target=xrefwindow id=d10682e5077 href="http://dx.doi.org/10.1038/sj.sc.3102007">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1907/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1907/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Institute of Medical Science, University of Toronto, Toronto, Canada<br/> <sup>2</sup> University of Toronto Spine Program, Toronto, Canada<br/> <sup>3</sup> Department of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Canada<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1907/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 30 Oct 2017, 6:1907 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11633.1">https://doi.org/10.12688/f1000research.11633.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Ulndreaj A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12564 data-id=11633 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11633.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1907/v1/pdf?article_uuid=fd432497-1a7a-49d1-99e4-096769ec9ba6" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11633.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Ulndreaj A, Badner A and Fehlings MG. Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1907 (<a href="https://doi.org/10.12688/f1000research.11633.1" target=_blank>https://doi.org/10.12688/f1000research.11633.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11633 id=mobile-track-article-signin-11633 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11633?target=/articles/6-1907/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12564 /> <input name=articleId type=hidden value=11633 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Patrick Freund</strong>, Spinal Cord Injury Center Balgrist, University Hospital Zurich, University of Zurich, Switzerland; Institute of Neurology, Wellcome Trust Center for Neuroimaging, University College London , UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Marios Papadopoulos</strong>, Academic Neurosurgery Unit, St. George's, University of London, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1907/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1907/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27359-27287></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15079-27285></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1907/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>30 Oct 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Patrick Freund</strong>, Spinal Cord Injury Center Balgrist, University Hospital Zurich, University of Zurich, Switzerland; Institute of Neurology, Wellcome Trust Center for Neuroimaging, University College London , UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Marios Papadopoulos</strong>, Academic Neurosurgery Unit, St. George's, University of London, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1907/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1907/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Promising neuroprotective strategies for...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1907/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1907/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1907/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Ulndreaj A et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1907/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1907",
            templates : {
                twitter : "Promising neuroprotective strategies for traumatic spinal cord.... Ulndreaj A et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1907/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11633/12564")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12564");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "27285": 0,
                           "27287": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "e98200b1-ebfe-4f6d-989c-89442e39efeb";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1907.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1907.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1907.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1907.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1907.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>